daunorubicin has been researched along with Benign Neoplasms in 259 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 139 (53.67) | 18.7374 |
| 1990's | 35 (13.51) | 18.2507 |
| 2000's | 37 (14.29) | 29.6817 |
| 2010's | 40 (15.44) | 24.3611 |
| 2020's | 8 (3.09) | 2.80 |
| Authors | Studies |
|---|---|
| Berscheid, HG; Böttger, D; Hermentin, P; Hoffmann, D; Kraemer, HP; Sedlacek, HH | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Chang, FS; Chen, W; Chen, YL; Tzeng, CC; Wang, C | 1 |
| Chen, YL; Cheng, CM; Han, CH; Lin, SR; Peng, SI; Tseng, CH; Tzeng, CC; Yang, SH | 1 |
| Baumert, C; Günthel, M; Hemmer, M; Hilgeroth, A; Krawczyk, S; Lage, H; Langner, A; Molnár, J; Wersig, T | 1 |
| Anikina, LV; Artyushin, OI; Brel, VK; Moiseeva, AA | 1 |
| Chatterjee, DR; Contractor, D; Jain, A; Kumar, D; Nagpure, M; Rana, P; Satpute, DP; Vaidya, GN; Venkatesh, A | 1 |
| Aguilar, LF; Coddou, C; Jara-Gutierrez, C; Mellado, M; Reyna-Jeldes, M; Villena, J; Weinstein-Oppenheimer, C | 1 |
| Goel, N; Kumar, N | 1 |
| Ghaemi, A; Pandey, S; Pourmadadi, M; Rahdar, A; Rajabzadeh-Khosroshahi, M; Shaghaghi, M; Shamsabadipour, A | 1 |
| Bucki, A; Jamrozik, M; Koczurkiewicz-Adamczyk, P; Kołaczkowski, M; Pękala, E; Piska, K | 1 |
| Das, KC; Kundumani-Sridharan, V; Muniyappa, H; Subramani, J | 1 |
| Byrne, ME; Mosley, RJ; Whitener, R; Wower, J | 1 |
| Hepel, M; Herschkowitz, JI; Kurzątkowska, K; Pazos, MA | 1 |
| Amiri, AH; Dalir Abdolahinia, E; Elahian, F; Ghamghami, M; Gholamian Dehkordi, N; Mirzaei, SA | 1 |
| Babaoğlu, K; Başar, EZ; Çetin, S; Çorapçıoğlu, F; Deveci, M | 1 |
| Chen, XL; Li, YY; Lin, HC; Liu, B; Liu, MC; Lu, JZ; Sun, XY; Yan, SQ; Zhang, LY; Zhao, P | 1 |
| Berkessel, A; Dragoun, M; Frias, C; Günther, T; Prokop, A | 1 |
| Adamkiewicz-Drożynska, E; Bączek, T; Bień, E; Kowalski, P; Krawczyk, MA; Maliszewska, O; Miękus, N; Olędzka, I; Plenis, A | 1 |
| Gajek, A; Marczak, A; Oszczapowicz, I; Rogalska, A; Łukawska, M | 1 |
| Chatgilialoglu, C; Efthimiadou, EK; Kordas, G; Toniolo, G | 1 |
| Arshad, N; Nosheen, B; Nowsherwan, J; Perveen, F; Qureshi, R; Rafique, H; Sultan, A | 1 |
| Louie, AC; Mayer, LD; Tardi, P | 1 |
| Chae, SW; Kim, HJ; Kim, NH; Lee, HJ; Lee, K; Rhie, S; Xia, Y | 1 |
| Choyke, PL; Kobayashi, H; Nakajima, T; Sano, K | 1 |
| Blanco, JG; Ferguson, D; Hageman Blair, R; Kalabus, JL; Quiñones-Lombraña, A; Redzematovic, A | 1 |
| Boukos, N; Efthimiadou, EK; Kordas, G; Tapeinos, C; Tziveleka, LA | 1 |
| Berg, SL; Broeckel, U; Delaney, SM; Devidas, M; Dolan, ME; Lorier, R; Reaman, GH; Scorsone, K; Sung, L; Thompson, P; Wheeler, HE | 1 |
| Ebert, B; Hintzpeter, J; Hornung, J; Martin, HJ; Maser, E | 1 |
| de Jong, J; Neefjes, J; Pang, B; Qiao, X; Wessels, LF | 1 |
| Gorbenko, AS; Olkhovskii, IA | 1 |
| Armstrong, GT; Caron, HN; Chow, EJ; Feijen, EA; Green, DM; Hudson, MM; Kremer, LC; Leisenring, WM; Ness, KK; Oeffinger, KC; Robison, LL; Stovall, M; Stratton, KL; van der Pal, HJ | 1 |
| Boušová, I; Matoušková, P; Skálová, L; Souček, P | 1 |
| Jiang, H; Li, J; Rehman, FU; Su, M; Wang, X; Wu, C; Ye, J; Zhang, Y | 1 |
| Cahlikova, L; Chlebek, J; Havrankova, J; Hofman, J; Hostalkova, A; Lundova, T; Musilek, K; Novotna, E; Wsol, V; Zemanova, L | 1 |
| Hatem, E; He, T; Huang, ME; Lei, M; Vernis, L | 1 |
| Cassinelli, G | 1 |
| Alves, AC; Horta, M; Lima, JL; Nunes, C; Reis, S; Ribeiro, D | 1 |
| Bacsó, Z; Goda, K; Szabó, G | 1 |
| Balendiran, GK | 1 |
| Chen, B; Guo, D; Jiang, H; Li, Q; Lu, X; Lv, G; Tian, H; Wang, X; Wu, C | 1 |
| Berg, H; Traitcheva, N | 1 |
| Lee, RJ; Li, H; Wu, J; Xiong, S; Yu, B | 1 |
| Gietema, JA; Postma, A; van den Berg, MP; van Spaendonck-Zwarts, KY; van Tintelen, JP; van Veldhuisen, DJ | 1 |
| Leurs, U; Manea, M; Marquardt, A; Mező, G; Öhlschläger, P; Orbán, E | 1 |
| Cox, NJ; Dolan, ME; Gamazon, ER; Huang, RS | 1 |
| Baranyai, Z; Kapuvári, B; Leurs, U; Manea, M; Marquardt, A; Mezo, G; Öhlschläger, P; Orbán, E; Schulcz, Á; Tejeda, M; Tóvári, J | 1 |
| Beck, WT; Bleeker, NP; Das, SG; Doshi, JM; Hermanson, DL; Srinivasan, B; Tang, R; Xing, C | 1 |
| Bánóczi, Z; Bosze, S; Csík, G; Fellinger, E; Hudecz, F; Manea, M; Marquadt, A; Orbán, E | 1 |
| Chen, Y; Feng, L; Han, W; Jin, H; Jin, W; Li, D; Pan, H; Pan, Q; Sun, J; Wang, K; Wang, X | 1 |
| Eun, JS; Lee, MK; Seo, SY; Yue, Y | 1 |
| Liu, Q; Luo, H; Qiu, L; Sun, D; Wang, F; Wang, PG; Yu, S; Zhang, G; Zhang, W | 1 |
| Panin, LE; Poliakov, LM; Sumenkova, DV | 1 |
| Bosch, SV; de Jonge, MJ; Fiorentini, F; Hess, D; Lechuga, MJ; Mantel, MA; Mora, O; Planting, AS; Sessa, C; Valota, O; van der Gaast, A; Verweij, J | 1 |
| Chan, PK | 1 |
| Chaloupka, V; Elbl, L; Hrstkova, H | 1 |
| Boos, J; Creutzig, U; Hempel, G; Reinhardt, D | 1 |
| DUBOST, M; GANTER, P; MARAL, R; NINET, L; PINNERT, S; PREUDHOMME, J; WERNER, GH | 2 |
| BELLINI, O; DIMARCO, A; DORIGOTTI, L; GAETANI, M; SOLDATI, M | 1 |
| DASDIA, T; DIMARCO, A; FIORETTI, A; SOLDATI, M | 1 |
| Bebawy, M; Fu, D; Kable, EP; Roufogalis, BD | 1 |
| Boronovskaia, LE; Korman, DB; Maslova, IA; Mikaélian, SG | 1 |
| Pui, KC | 1 |
| Jaffrezou, JP; Laurent, G | 1 |
| Barnes, C; Blanchette, V; Canning, P; Greenberg, M; Price, V | 1 |
| Blazek, B; Elbl, L; Hrstkova, H; Michalek, J; Tomaskova, I | 1 |
| Hu, X; Lu, Q; Qiangrong, P; Wang, T | 1 |
| Chin, C; Chow, AY; Dahl, G; Rosenthal, DN | 1 |
| Adt, I; Kartha, VB; Kegelaer, G; Krishna, CM; Manfait, M; Rubin, S; Sockalingum, GD | 1 |
| Bally, MB; Harasym, NL; Harasym, TO; Janoff, AS; Johnstone, SA; Mayer, LD; Ramsay, EC; Shew, CR; Tardi, PG | 1 |
| Cao, X; Dai, Z; Fang, L; Gibbs, S; Huang, Y; Sadee, W; Sun, D; Wen, P; Zheng, X | 1 |
| Carlsson, J; Edwards, K; Gedda, L; Ickenstein, LM; Sjöberg, S | 1 |
| Bijnens, B; Claus, P; D'hooge, J; Eyskens, B; Ganame, J; Gewillig, M; Mertens, L; Renard, M; Sutherland, GR; Uyttebroeck, A | 1 |
| Bubici, C; Franzoso, G; Knabb, JR; Kuntzen, C; Papa, S; Pham, CG; Zazzeroni, F | 1 |
| Clark, SJ; Hemsworth, S; Newland, P; Pippon, M; Pizer, B | 1 |
| Gassner, B; Gekle, M; Kelleher, DK; Schwerdt, G; Thews, O | 1 |
| de Camargo, B; Deheinzelin, D; Junior, SP; Lopes, LF; Santin, JC | 1 |
| Chen, B; Fu, D; Li, J; Song, M; Wang, X; Zhang, R | 1 |
| Balendiran, GK; Haq, W; Martin, HJ; Maser, E; O'Connor, TR; Verma, M | 1 |
| Bleibel, WK; Das, S; Delaney, SM; Dolan, ME; Duan, S; Fackenthal, DL; Huang, RS; Kistner, EO | 1 |
| Fekete, G; Schuler, D; Szollár, J | 1 |
| Gause, GF | 1 |
| Burke, PJ; Karp, JE; Vaughan, WP | 1 |
| Baldwin, RW; Gallego, J; Price, MR | 1 |
| Stroshane, RM | 1 |
| Spreafico, F | 2 |
| Allegra, JC; Blumenreich, MS; Gentile, P; Jones, M; Kubota, TT; Lalley, K; Richman, SP; Seeger, J; Woodcock, TM | 1 |
| Von Hoff, DD | 1 |
| Goodman, A; Harvey, J; McFadden, M; Schein, P; Smith, F | 1 |
| Foo, W; Goodman, A; Harvey, J; Rahman, A; Schein, PS; Smith, FP | 1 |
| Beck, JR; Cohen, SR; Ferrans, VJ; Gottdiener, JS; Isner, JM; Roberts, WC; Virmani, R; Witkind, BG | 1 |
| Baratz, R; Berman, E; Casper, ES; Gralla, RJ; Howard, J; Leyland-Jones, B; Williams, L; Wittes, RE; Young, CW | 1 |
| Bonadonna, G; Bonfante, V; Ferrari, L; Villani, F | 1 |
| Cavalli, F; Kaplan, S; Pacciarini, MA; Sessa, C; Tamassia, V; Willems, Y | 1 |
| Reich, SD | 2 |
| Oka, S; Oki, T; Takeuchi, T; Umezawa, H | 1 |
| Crouse, VL; Evans, W; Lewis, AB; Siegel, SE; Takahashi, M | 1 |
| Cavalli, F; Kaplan, S; Martini, A; Togni, P; Varini, M | 1 |
| Bruno, S; Macdonald, JS; Marsoni, S; Penta, J; Poster, DS | 1 |
| Arnon, R; Sela, M | 1 |
| Bruno, S; Weiss, RB | 1 |
| Piccart, M; Rozencweig, M; Von Hoff, DD | 1 |
| Aust, JC; Comis, RL; Crooke, ST; DiFino, SM; Ginsberg, SJ; Issell, BF; Pittman, K; Poiesz, BJ; Rudolph, A; Tinsley, RW | 1 |
| Kuikka, J; Lahtinen, R; Länsimies, E; Uusitupa, M | 1 |
| Baurain, R; Deprez-de Campeneere, D; Masquelier, M; Trouet, A | 1 |
| Abele, R; Bedogni, P; Body, JJ; Crooke, ST; Kenis, Y; Lenaz, L; Reich, SD; Rozencweig, M | 1 |
| Baker, LH; Comis, RL; Crooke, ST; Ginsberg, SJ; Reich, SD | 1 |
| Fandrich, SE; Pittman, KA | 1 |
| Auclerc, G; Auclerc, MF; Bernard, J; Cueille, G; Heusse, D; Jacquillat, C; Lavelle, F; Maral, J; Maral, R; Marlard, M; Weil, M | 1 |
| Heinze, F; Henze, G; Holtgrave, EA | 1 |
| Bors, V; Dorent, R; Gandjbakhch, I; Ghoussoub, JJ; Nataf, P; Pavie, A; Tedy, G; Vaissier, E | 1 |
| Boven, E; Broxterman, HJ; Feller, N; Kuiper, CM; Lankelma, J; Pinedo, HM; Teerlink, T; Versantvoort, CH | 1 |
| Andolina, M; Arrighini, A; Barisone, E; Brach del Prever, A; Leone, L; Madon, E; Massara, FM; Miniero, R; Saroglia, EM; Soldano, S | 1 |
| Nishimura, S; Saito, H; Sakurai, T; Sasaki, Y; Shibu, T; Sukekawa, H; Takeishi, Y; Tomoike, H | 1 |
| Broxterman, HJ; Eekman, CA; Kuiper, CM; Lankelma, J; Pinedo, HM; Schuurhuis, GJ; Versantvoort, CH | 1 |
| Andreoni, A; Colasanti, A; Kisslinger, A; Mastrocinque, M; Riccio, P; Roberti, G | 1 |
| Hutchinson, CR | 1 |
| Lundström, U; Pesonen, E; Pihkala, J; Saarinen, UM; Siimes, MA; Virkola, K; Virtanen, K | 1 |
| Ríhová, B | 1 |
| Baldwin, AS; Mayo, MW; Wang, CY | 1 |
| Huang, GY; Lau, J; Li, CK; Oppenheimer, SJ; Shing, MK; Sung, RY; Yuen, MP | 1 |
| Hortobágyi, GN | 1 |
| Fukuda, H; Kunitoh, H; Saijo, N; Sekine, I | 1 |
| Cummings, J; Samuel, L; Shaw, P | 1 |
| DeJesus, OT; Murali, D | 1 |
| Gewirtz, DA | 1 |
| de Vries, EG; Eriks-Fluks, L; Franssen, EJ; Hendrikse, NH; Hospers, GA; Vaalburg, W; van der Graaf, WT; Willemsen, AT | 1 |
| Ax, W; Koch, L; Maser, E; Plebuch, M; Soldan, M | 1 |
| Koch, L; Maser, E; Soldan, M | 1 |
| Koo, HM; Vande Woude, GF | 1 |
| Foltinova, A; Hulin, I; Mladosievicova, B; Petrasova, H | 1 |
| Harrington, KJ; Lewanski, CR; Stewart, JS | 1 |
| Fernandez, H; Hu, YP; Krishan, A; Lyubimov, E; Mou, C; Sridhar, KS; Stein, WD | 1 |
| Brouwer, E; Nooter, K; Sparreboom, A; Stoter, G; van Zuylen, L; Verweij, J | 1 |
| Hellström, I; Hellström, KE; Senter, PD | 1 |
| Monneret, C | 1 |
| Aouali, N; Belhoussine, R; Levade, T; Manfait, M; Morjani, H; Veldman, RJ | 1 |
| Hirano, T; Liu, ZL; Oka, K; Onda, K; Tanaka, S; Toma, T | 1 |
| Bénard, J; Charpentier, B; Cherbonnier, C; Déas, O; Dürrbach, A; Haeffner, A; Hirsch, F; Merlin, JL; Senik, A; Vassal, G | 1 |
| Egilsson, V; Evans, IH; Wilkie, D | 1 |
| Douros, JD | 1 |
| Schein, PS; Winokur, SH | 1 |
| Chabner, BA; Myers, CE; Oliverio, VT | 1 |
| Umezawa, H | 1 |
| Carter, SB; Friedman, MA | 1 |
| Beran, M; Semonská, S; Semonský, M | 1 |
| Hinderer, H; Kaufmann, M; Mattern, J; Volm, M; Wayss, K | 1 |
| Sullivan, MP; Sutow, WW | 1 |
| Holland, JF; Silver, RT; Young, RC | 1 |
| Sokal, G; Trouet, A | 1 |
| Haskell, CM | 1 |
| Grindey, GB; Mihich, E | 1 |
| Garattini, S; Spreafico, F | 1 |
| Arnon, R | 1 |
| Strauss, DG | 1 |
| Hansen, HH; Mouridsen, HT; Nissen, NI; Pedersen-Bjergaard, J; Skovsgaard, T | 1 |
| Benjamin, RS | 1 |
| Davis, HL; Davis, TE | 1 |
| Cox, PJ; Farmer, PB | 1 |
| Ames, MM; Kovach, JS; O'Connell, MJ; Sternad, ML | 1 |
| Auclerc, G; Auclerc, MF; Bernard, J; Degos, L; Jacquillat, C; Maral, J; Schaison, G; Tobelem, G; Weil, M | 1 |
| Barthelemy, C; Clavel, B; Guérin, JC; Moindrot, J; Simon, J | 1 |
| Auclerc, MF; Bernard, J; Boiron, M; Jacquillat, C; Maral, J; Schaison, G; Weil, M | 1 |
| Deprez-De Campeneere, D; Trouet, A | 1 |
| Lewis, AB; Pilkington, R; Siegel, SE; Takahashi, M | 1 |
| Bassleer, R; Chévremont, M | 1 |
| De Duve, C | 1 |
| Bachur, NR; Green, MR; Langone, JJ; Levine, L; Riggs, CE; Van Vunakis, H | 1 |
| Byfield, JE; Chan, PY; Kulhanian, F; Lynch, M | 1 |
| Bech-Hansen, NT; Ling, V; Sarangi, F; Sutherland, DJ | 1 |
| Gross, R; Hirschmann, WD | 1 |
| Muggia, FM; Rozencweig, M; Slavik, M; Von Hoff, DD | 1 |
| Schwartz, HS | 1 |
| Dano, K | 1 |
| Nissen, NI; Skovsgaard, T | 1 |
| Connors, TA | 1 |
| Gilladoga, AC; Manuel, C; Murphy, ML; Sternberg, SS; Tan, CT; Wollner, N | 1 |
| Canty, A; Dyson, PG; Haylock, DN; Juttner, CA; Thorp, D; To, LB | 1 |
| Carpentier, Y; Desoize, B; Gorisse, MC | 1 |
| Weiss, RB | 1 |
| Eden, OB; Elton, R; Shaw, NJ | 1 |
| Carlsson, J; Daniel-Szolgay, E; Erlanson, M | 1 |
| Camaggi, CM; Carisi, P; Efthymiopoulos, C; Guaraldi, M; Martoni, A; Pannuti, F; Strocchi, E; Strolin-Benedetti, M; Tononi, A | 1 |
| Galbraith, A; Smith, PJ; Spink, J; Yeung, ST; Yoong, C | 1 |
| Buono, S; Coppolino, P; Gualtieri, S; Iacono, A; Iarussi, D; Pisacane, C | 1 |
| Schott, G | 1 |
| Steinherz, L; Steinherz, P | 1 |
| Hellstrom, I; Hellstrom, KE; Hill, L; Hirschberg, DL; Lavie, E; Schreiber, G; Thor, K | 1 |
| D'Incalci, M; Erranti, D; Freshi, A; Tirelli, U; Zanette, L; Zucchetti, M | 1 |
| Earhart, RH; Maroun, JA; Perrault, D; Stewart, DJ; Verma, S | 1 |
| Bleyer, WA | 1 |
| Escriba, PV; Ferragut, JA; Ferrer-Montiel, AV; González-Ros, JM; Soto, F | 1 |
| Bugat, R; Carton, P; Coulais, Y; Houin, G; Labat, C; Oustrin, J; Sqalli, A | 1 |
| Gray, RG; Hayhoe, FG; Rees, JK; Swirsky, D | 1 |
| Benson, LN; Chan, H; Langevin, A; Souza, MD; Stein, JI; Wilson, G | 1 |
| Aisner, J; Egorin, MJ; Sigman, LM; Van Echo, DA; Whitacre, MY | 1 |
| Long, HJ; Moertel, CG; Powis, G; Schutt, AJ | 1 |
| D'Incalci, M; Figoli, F; Monfardini, S; Sorio, R; Tirelli, U; Zadro, D; Zanette, ML | 1 |
| Conley, BA; Egorin, MJ; Forrest, A; Sinibaldi, V; Van Echo, DA; Zuhowski, EG | 1 |
| Crespeigne, N; de Valeriola, D; Dodion, P; Joggi, J; Kenis, Y; Peeters, B; Piccart, M; Tueni, E; van Berchem, C; Wery, F | 1 |
| Crespeigne, N; de Valeriola, D; Dodion, P; Joggi, J; Kenis, Y; Peeters, B; van Berchem, C; Wery, F | 1 |
| D'iachkovskaia, RF; Ganieva, LKh; Konovalova, NP; Lapshin, IM; Volkova, LM | 1 |
| LeBaron, C; LeBaron, S; Scott, SE; Zeltzer, LK; Zeltzer, PM | 1 |
| Arcamone, F | 1 |
| Beer, M; Crespeigne, N; Dodion, P; Finet, C; Kenis, Y; Nicaise, C; Rozencweig, M | 1 |
| Akiyama, S; Kuratomi, Y; Kuwano, M; Nakagawa, M; Shiraishi, N | 1 |
| Gillies, HC; Harper, PG; Herriott, D; Liang, R; Ohashi, K; Rogers, HJ | 1 |
| Bacha, DM; Dantis, E; Hancock, C; Luks, E; Meyers, P; Mondora, A; Steinherz, L; Steinherz, P; Tan, CT; Winick, N | 1 |
| Ganzina, F; Hurteloup, P | 1 |
| Davila, E; Krishan, A; Sridhar, KS; Sternheim, W; Vogel, C | 1 |
| Kavanagh, JJ; Krakoff, IH; Savaraj, N; Yeung, KY | 1 |
| Takaku, F | 1 |
| Ogawa, M | 1 |
| Burrows, FA; Colan, S; Hickey, PR | 1 |
| Bloomfield, CD; Duane, SF; Hurd, DD; Michels, SD; Peterson, BA | 1 |
| Dold, U; Schmidt, CG | 1 |
| Oara, H; Wada, T | 1 |
| Zdichynec, B | 1 |
| Bergevin, PR; Blom, J; Tormey, DC | 1 |
| Greenwald, ES | 1 |
| Goerttler, K; Kaufmann, M; Mattern, J; Volm, M; Wayss, K | 1 |
| Buja, LM; Ferrans, VJ; Rabson, AS | 1 |
| Mattern, J; Volm, M; Wayss, K | 1 |
| Artico, M | 1 |
| Krasil'nikov, NA; Kuimova, TF | 1 |
| Astrakhan, VI; Garin, AM | 1 |
| Fortuna, E; Fossati-Guglielmoni, A; Massimo, L | 2 |
| Sporn, MB | 1 |
| Frei, E; Lokich, JJ; Skarin, AT | 1 |
| Henry, DW | 1 |
| Praga, C | 1 |
| Amiel, JL; Beyer, HP; de Vassal, F; Fajbisowicz, S; Hayat, M; Jasmin, C; Mathé, G; Pouillart, P; Schneider, M; Schwarzenberg, L; Weiner, R | 1 |
| Chandra, P; Gericke, D; Thorbeck, R; Zunino, F | 1 |
| Berndt, H; Rieche, K | 1 |
| Brunner, KW | 1 |
| Hozumi, M | 1 |
| Hawk, IA; Levy, CC; Russell, DH; Schimpff, SC | 1 |
| Henderson, ES; Serpick, AA | 1 |
| Esposito, S; Taylor, LA | 1 |
| Esposito, M; Ravazzoni, C; Rosso, R; Sala, R; Santi, L | 1 |
| Di Marco, A; Lenaz, L | 1 |
| Biedler, JL; Riehm, H | 1 |
| Di Marco, A; Massimo, L | 1 |
| Mathé, G | 1 |
| Curtis, AB; Stern, MH | 1 |
| Dunston, L; Falkson, G; Falkson, HC | 1 |
| Fortuna, D; Fossati-Guglielmoni, A; Massimo, L | 1 |
49 review(s) available for daunorubicin and Benign Neoplasms
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Paradigm shift of "classical" HDAC inhibitors to "hybrid" HDAC inhibitors in therapeutic interventions.
Topics: Animals; Cardiovascular Diseases; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Humans; Molecular Targeted Therapy; Neoplasms; Nervous System Diseases | 2021 |
Nanoparticles loaded with Daunorubicin as an advanced tool for cancer therapy.
Topics: Antineoplastic Agents; Daunorubicin; Drug Carriers; Drug Delivery Systems; Humans; Nanoparticles; Neoplasms | 2023 |
CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties.
Topics: Cytarabine; Daunorubicin; Drug Compounding; Endocytosis; Humans; Liposomes; Neoplasms; Tissue Distribution | 2019 |
The modulation of carbonyl reductase 1 by polyphenols.
Topics: Alcohol Oxidoreductases; Animals; Bupropion; Butanones; Butyrophenones; Daunorubicin; Doxorubicin; Gene Expression Regulation, Enzymologic; Haloperidol; Humans; Indoles; Nabumetone; Neoplasms; Phenylpropionates; Polyphenols; Quinolizines; Substrate Specificity; Xenobiotics | 2015 |
The roots of modern oncology: from discovery of new antitumor anthracyclines to their clinical use.
Topics: Academies and Institutes; Anthracyclines; Antibiotics, Antineoplastic; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Approval; Drug Discovery; Drug Industry; France; History, 20th Century; History, 21st Century; Humans; Interdisciplinary Communication; Italy; Medical Oncology; Neoplasms; Patents as Topic; Public-Private Sector Partnerships; Streptomyces; Translational Research, Biomedical; United States | 2016 |
Multidrug resistance through the spectacle of P-glycoprotein.
Topics: Algorithms; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cloning, Molecular; Daunorubicin; Drug Resistance, Multiple; Genes, MDR; Humans; Kinetics; Models, Genetic; Neoplasms; Rhodamine 123 | 2009 |
Fibrates in the chemical action of daunorubicin.
Topics: Aldehyde Reductase; Aldo-Keto Reductases; Antibiotics, Antineoplastic; Clofibric Acid; Daunorubicin; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Models, Molecular; Neoplasms; Substrate Specificity | 2009 |
Ceramide : A New Target in Anticancer Research?
Topics: Antibiotics, Antineoplastic; Apoptosis; Ceramides; Daunorubicin; Diglycerides; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Neoplasms; Phosphatidylinositol 3-Kinases; Protein Kinase C; Serine Endopeptidases; Sphingomyelin Phosphodiesterase; Sphingomyelins | 2004 |
Antitumor antibiotic carminomycin.
Topics: Animals; Biological Transport; Carubicin; Chemical Phenomena; Chemistry; Daunorubicin; DNA; Humans; Mice; Neoplasms; Neoplasms, Experimental; Nocardia; Protein Biosynthesis; RNA | 1980 |
Production of daunorubicin.
Topics: Culture Media; Daunorubicin; Fermentation; Humans; Indicators and Reagents; Neoplasms; Species Specificity; Streptomyces | 1984 |
Heterogeneity of the interaction of anticancer agents with the immune system and its possible relevance in chemoimmunotherapy.
Topics: Animals; Antineoplastic Agents; Cytotoxicity, Immunologic; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Humans; Immunity, Cellular; Immunotherapy; Neoplasms; Neoplasms, Experimental | 1980 |
In vitro and in vivo efficacy of conjugates of daunomycin with anti-tumor antibodies.
Topics: Animals; Antibodies, Neoplasm; Antibody Specificity; Daunorubicin; Doxorubicin; Drug Combinations; Drug Evaluation, Preclinical; Immunoglobulin Fab Fragments; Liver Neoplasms; Liver Neoplasms, Experimental; Lymphoma; Macromolecular Substances; Mice; Neoplasms; Neoplasms, Experimental; Rats | 1982 |
Daunorubicin treatment of adult solid tumors.
Topics: Adult; Clinical Trials as Topic; Colonic Neoplasms; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Lymphoma; Male; Neoplasms; Sarcoma; Urinary Bladder Neoplasms | 1981 |
Anthracyclines.
Topics: Amino Acid Sequence; Animals; Antibiotics, Antineoplastic; Bacterial Proteins; Carbohydrate Sequence; Cattle; Daunorubicin; DNA-Binding Proteins; Doxorubicin; Genes, Bacterial; Humans; Molecular Sequence Data; Molecular Structure; Multigene Family; Neoplasms; Promoter Regions, Genetic; Repressor Proteins; Sequence Homology, Amino Acid; Streptomyces | 1995 |
Antibody-targeted polymer-bound drugs.
Topics: Acrylamides; Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antineoplastic Agents; Chlorophyllides; Clinical Trials as Topic; Cyclosporine; Daunorubicin; Doxorubicin; Histocompatibility Antigens Class II; Humans; Immune System Diseases; Immunoconjugates; Immunosuppressive Agents; Lysosomes; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Polymethacrylic Acids; Porphyrins; Radiation-Sensitizing Agents; T-Lymphocyte Subsets; Thy-1 Antigens; Tissue Distribution | 1995 |
Anthracyclines in the treatment of cancer. An overview.
Topics: Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Heart Diseases; Humans; Leukemia; Neoplasms; Neutropenia; Stomatitis | 1997 |
Cancer chemotherapy in the elderly.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Busulfan; Daunorubicin; Doxorubicin; Etoposide; Female; Fluorouracil; Heart; Hematologic Neoplasms; Humans; Lung; Male; Middle Aged; Neoplasms; Pyrazoles | 1998 |
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Daunorubicin; DNA Damage; DNA, Neoplasm; Doxorubicin; Free Radicals; Glutathione; Heart; Humans; Lipid Peroxidation; Neoplasms | 1999 |
Liposomes as vehicles for targeted therapy of cancer. Part 2: clinical development.
Topics: Antineoplastic Agents; Biological Availability; Cisplatin; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Carriers; Humans; Liposomes; Neoplasms | 2000 |
Development and activities of the BR96-doxorubicin immunoconjugate.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antigens, Neoplasm; Carcinoma; Clinical Trials, Phase I as Topic; Colonic Neoplasms; Daunorubicin; Digestive System; Doxorubicin; Drug Design; Gastrointestinal Diseases; Humans; Immunotoxins; Lewis Blood Group Antigens; Mice; Mice, Nude; Neoplasms; Neoplasms, Experimental; Organ Specificity; Rats; Rats, Inbred BN; Rats, Nude; Treatment Failure; Xenograft Model Antitumor Assays | 2001 |
Recent developments in the field of antitumour anthracyclines.
Topics: Aclarubicin; Amino Acid Sequence; Animals; Anthracyclines; Antineoplastic Agents; Carubicin; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Humans; Neoplasms | 2001 |
Immunosuppressive and cytotoxic chemotherapy: long-term complications.
Topics: Alkylating Agents; Antineoplastic Agents; Azathioprine; Bleomycin; Busulfan; Carcinogens; Chemical and Drug Induced Liver Injury; Daunorubicin; Doxorubicin; Female; Fetus; Folic Acid Antagonists; Follow-Up Studies; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infertility, Female; Infertility, Male; Liver; Lung Diseases; Male; Mercaptopurine; Methotrexate; Myocarditis; Neoplasms; Ovary; Pregnancy; Procarbazine; Streptozocin; Testis; Urologic Diseases | 1975 |
Serious toxicities associated with chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Asparaginase; Bleomycin; Cisplatin; Cyclophosphamide; Daunorubicin; Doxorubicin; Emergencies; Estradiol Congeners; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasms; Nitrosourea Compounds; Plicamycin; Testosterone Congeners; Vinca Alkaloids | 1978 |
[Chemotherapy of invasive tumors. VI. Antibiotics].
Topics: Antibiotics, Antineoplastic; Bleomycin; Dactinomycin; Daunorubicin; Doxorubicin; Humans; Neoplasms; Olivomycins; Plicamycin; Streptonigrin | 1979 |
Immunologic aspects of cancer chemotherapy.
Topics: Animals; BCG Vaccine; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Immunotherapy; Levamisole; Mercaptopurine; Methotrexate; Mice; Neoplasms; Propionibacterium acnes; Vinca Alkaloids | 1977 |
Multiple basis of combination chemotherapy.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Antagonism; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Humans; Leucovorin; Mercaptopurine; Methotrexate; Neoplasms; Neoplasms, Experimental; Uridine | 1977 |
Some examples of interactions between drugs in cancer chemotherapy.
Topics: Animals; Bacterial Vaccines; Cyclophosphamide; Daunorubicin; Doxorubicin; Drug Interactions; Drug Therapy, Combination; Humans; Immunotherapy; Neoplasms; Phenobarbital; Propionibacterium acnes | 1978 |
Site-directed tumor chemotherapy.
Topics: Animals; Antibodies, Neoplasm; Daunorubicin; Humans; Leukemia, Experimental; Lymphoma; Lysosomes; Mice; Mice, Inbred A; Mice, Inbred BALB C; Neoplasms; Plasmacytoma | 1978 |
Anthracyclines--modern tumour-inhibiting agents.
Topics: Animals; Antibiotics, Antineoplastic; Bacteria; Chemical Phenomena; Chemistry; Daunorubicin; Doxorubicin; Glycosides; Humans; Naphthacenes; Neoplasms; Nogalamycin | 1978 |
Adriamycin and other anthracycline antibiotics under study in the United States.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Daunorubicin; Doxorubicin; Drug Combinations; Hodgkin Disease; Humans; Leukemia; Neoplasm Metastasis; Neoplasms; Soft Tissue Neoplasms; United States | 1978 |
Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations.
Topics: Breast Neoplasms; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia; Lymphoma; Neoplasms; Sarcoma; Soft Tissue Neoplasms | 1979 |
Towards selectivity? Approaches to the design of new anti-tumour agents--II.
Topics: Altretamine; Amino Acids; Antineoplastic Agents; Carbohydrates; Chelating Agents; Colchicine; Coloring Agents; Dacarbazine; Daunorubicin; Doxorubicin; Drug Interactions; Ellipticines; Folic Acid Antagonists; Heart Diseases; Humans; Lectins; Neoplasms; Nitrosourea Compounds; Peptide Hydrolases; Podophyllotoxin; Polymers; Structure-Activity Relationship | 1977 |
Adriamycin, an antitumour antibiotic: a review with special reference to daunomycin.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Humans; Neoplasms | 1975 |
Drugs used in the treatment of cancer.
Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Binding Sites; Cell Division; Cisplatin; Daunorubicin; DNA; Doxorubicin; Humans; Leukemia L1210; Mice; Microsomes, Liver; Neoplasms; Structure-Activity Relationship | 1975 |
The anthracyclines: will we ever find a better doxorubicin?
Topics: Animals; Antibiotics, Antineoplastic; Chemistry, Pharmaceutical; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Evaluation; Drugs, Investigational; Heart Diseases; Humans; Neoplasms | 1992 |
Cancer chemotherapy in infants and children.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bleomycin; Catheters, Indwelling; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Dactinomycin; Daunorubicin; Doxorubicin; Humans; Infant; Infant, Newborn; Infusions, Parenteral; Mercaptopurine; Methotrexate; Neoplasms; Nitrosourea Compounds; Thioguanine; Vinblastine; Vincristine | 1985 |
Interaction of anthracyclines with plasma membranes from tumour cells: implications on drug resistance.
Topics: Animals; Antibiotics, Antineoplastic; Cell Membrane; Daunorubicin; Drug Resistance; Humans; Membrane Lipids; Neoplasms; Tumor Cells, Cultured | 1989 |
Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicin.
Topics: Antibiotics, Antineoplastic; Bone Marrow; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Heart; Humans; Idarubicin; Neoplasms | 1986 |
[Current status of clinical results of new antitumor drugs].
Topics: Aminoacridines; Amsacrine; Anthracyclines; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Aziridines; Benzoquinones; Carboplatin; Carubicin; Cisplatin; Daunorubicin; Doxorubicin; Eflornithine; Epirubicin; Humans; Idarubicin; Mitoxantrone; Naphthacenes; Neoplasms; Organoplatinum Compounds; Ornithine; Ribavirin | 1985 |
[Cytostatic antibiotics].
Topics: Amino Sugars; Animals; Antibiotics, Antineoplastic; Cell Division; Chemical Phenomena; Chemistry; Dactinomycin; Daunorubicin; DNA, Neoplasm; Humans; Mitomycins; Neoplasm Metastasis; Neoplasms; Nitroso Compounds; RNA, Neoplasm; Stomach Neoplasms | 1971 |
[Tumors].
Topics: Antigens; Bleomycin; Daunorubicin; Fetal Proteins; Fluorouracil; Glycolipids; Glycoproteins; Humans; Lung Neoplasms; Neoplasms; Radioimmunoassay; Radionuclide Imaging; Stomach Neoplasms | 1972 |
Guide to the use of cancer chemotherapeutic agents.
Topics: Alkylating Agents; Allopurinol; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Asparaginase; Azaserine; Azauridine; Bleomycin; Camptothecin; Carmustine; Cell Division; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Fluorouracil; Humans; Kinetics; Neoplasms; Nitrogen Mustard Compounds; Procarbazine; Triazines; Vincristine | 1972 |
Cancer chemotherapy. II.
Topics: Animals; Antineoplastic Agents; Asparaginase; Azathioprine; Bleomycin; Cytarabine; Dactinomycin; Daunorubicin; Dimethylamines; Doxorubicin; Floxuridine; Fluorouracil; Humans; Hydroxyurea; Imidazoles; Mercaptopurine; Mitomycins; Mitotane; Neoplasms; Nitrosourea Compounds; Pipobroman; Procarbazine; Streptonigrin; Streptozocin; Thioguanine; Triazenes; Triazines; Vinblastine; Vincristine | 1972 |
[Chemotherapy of tumors. 3. Chemical review of natural antineoplastic agents: antibiotics and related compounds; enzymes and hormones].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Bleomycin; Dactinomycin; Daunorubicin; Diethylstilbestrol; Humans; Hydroxyprogesterones; Mitomycins; Mycophenolic Acid; Nandrolone; Neoplasms; Nitrosourea Compounds; Olivomycins; Steroids; Streptonigrin | 1974 |
[Clinical use of antitumor antibiotics].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Dactinomycin; Daunorubicin; Flavonoids; Humans; Neoplasms; Olivomycins; Streptonigrin | 1967 |
[Molecular basis of viral induced tumors (author's transl)].
Topics: Amidines; Animals; Anti-Bacterial Agents; Cell Transformation, Neoplastic; Daunorubicin; DNA Nucleotidyltransferases; DNA Viruses; Doxorubicin; Humans; Neoplasms; Oncogenic Viruses; Peptides; Pyrroles; RNA Viruses | 1973 |
[Progress in the drug therapy of cancer].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Cytarabine; Daunorubicin; Drug Synergism; Humans; Hydrazines; Hydroxyurea; Neoplasms; Nitroso Compounds; Picolinic Acids; Pyrogallol; Quinolines; Streptonigrin; Urea | 1968 |
[Instability of phenotypes of tumor cells--on decarcinogenesis].
Topics: Amphibians; Animals; Anura; Bromodeoxyuridine; Carcinogens; Cell Differentiation; Cell Fusion; Cell Membrane; Dactinomycin; Daunorubicin; Hexokinase; Humans; Isoenzymes; Mice; Neoplasm Regression, Spontaneous; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Nitrosourea Compounds; Phenotype; Quinolines | 1971 |
15 trial(s) available for daunorubicin and Benign Neoplasms
| Article | Year |
|---|---|
Phase I and pharmacokinetic studies of PNU-159548, a novel alkycycline, administered intravenously to patients with advanced solid tumours.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Daunorubicin; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Vomiting | 2002 |
Population pharmacokinetics of liposomal daunorubicin in children.
Topics: Acute Disease; Adolescent; Adult; Antibiotics, Antineoplastic; Child; Child, Preschool; Daunorubicin; Drug Carriers; Humans; Infant; Infusions, Intravenous; Leukemia, Myeloid; Liposomes; Neoplasms; Recurrence | 2003 |
[Results of a phase I-II clinical trial of Emoxyl, a novel antineoplastic anthracycline].
Topics: Aged; Anthracyclines; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Small Cell; Daunorubicin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Sarcoma, Kaposi; Treatment Outcome | 2004 |
Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients.
Topics: Adolescent; Anthracyclines; Antineoplastic Agents; Blood Pressure; Body Mass Index; Cardiovascular Agents; Child; Child, Preschool; Czech Republic; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Echocardiography, Stress; Female; Follow-Up Studies; Heart; Heart Rate; Humans; Infant; Male; Neoplasms; Prospective Studies; Razoxane; Time Factors; Treatment Outcome | 2005 |
Effective chemotherapy of acute myelocytic leukemia occurring after alkylating agent or radiation therapy for prior malignancy.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Male; Middle Aged; Neoplasms; Prospective Studies; Risk | 1983 |
Daunorubicin: a brief review.
Topics: Clinical Trials as Topic; Daunorubicin; Humans; Neoplasms | 1980 |
Bis-diketopiperazine derivatives in clinical oncology: ICRF-159.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Evaluation; Drug Interactions; Head and Neck Neoplasms; Humans; Lymphoma; Mice; Neoplasm Metastasis; Neoplasms; Piperazines; Razoxane | 1980 |
Daunorubicin treatment of adult solid tumors.
Topics: Adult; Clinical Trials as Topic; Colonic Neoplasms; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Lymphoma; Male; Neoplasms; Sarcoma; Urinary Bladder Neoplasms | 1981 |
Noninvasive identification of anthracycline cardiotoxicity: comparison of 123I-MIBG and 123I-BMIPP imaging.
Topics: 3-Iodobenzylguanidine; Aclarubicin; Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Echocardiography; Fatty Acids; Female; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neoplasms; Radionuclide Imaging | 1994 |
Synergistic effect of prochlorperazine and dipyridamole on the cellular retention and cytotoxicity of doxorubicin.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Cell Survival; Colonic Neoplasms; Culture Media; Daunorubicin; Dipyridamole; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Infusions, Intravenous; Metabolic Clearance Rate; Neoplasms; Plasma; Prochlorperazine; Tumor Cells, Cultured | 2000 |
Clinical studies with daunorubicin-DNA and adriamycin-DNA complexes: a review.
Topics: Animals; Child; Daunorubicin; Disease Models, Animal; DNA; DNA Adducts; Doxorubicin; Drug Combinations; Humans; Leukemia; Leukemia, Lymphoid; Mice; Neoplasms; Neoplasms, Experimental; Random Allocation | 1979 |
Clinical trial of rubidazone in solid tumors and malignant lymphomas.
Topics: Adult; Aged; Clinical Trials as Topic; Daunorubicin; Drug Evaluation; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Neoplasms | 1978 |
Idarubicin metabolism and pharmacokinetics after intravenous and oral administration in cancer patients: a crossover study.
Topics: Administration, Oral; Biological Availability; Daunorubicin; Glycosylation; Humans; Idarubicin; Infusions, Intravenous; Kidney; Kidney Diseases; Liver Neoplasms; Neoplasms | 1992 |
Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Central Nervous System Diseases; Child; Child, Preschool; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Administration Schedule; Humans; Infant; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Prognosis; Random Allocation; Thioguanine | 1986 |
Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicin.
Topics: Antibiotics, Antineoplastic; Bone Marrow; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Heart; Humans; Idarubicin; Neoplasms | 1986 |
197 other study(ies) available for daunorubicin and Benign Neoplasms
| Article | Year |
|---|---|
Structure-activity relationship of anthracyclines in vitro.
Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry, Physical; Colonic Neoplasms; DNA; Humans; Leukemia L1210; Molecular Structure; Neoplasms; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Synthesis and antiproliferative evaluations of certain 2-phenylvinylquinoline (2-styrylquinoline) and 2-furanylvinylquinoline derivatives.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Neoplasms; Quinolines | 2010 |
Synthesis and antiproliferative evaluation of certain iminonaphtho[2,3-b]furan derivatives.
Topics: Antineoplastic Agents; Benzofurans; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; DNA Fragmentation; Drug Screening Assays, Antitumor; Fibroblasts; Humans; Imines; Neoplasms | 2010 |
Development of small-molecule P-gp inhibitors of the N-benzyl 1,4-dihydropyridine type: novel aspects in SAR and bioanalytical evaluation of multidrug resistance (MDR) reversal properties.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Daunorubicin; Dihydropyridines; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Mice; Neoplasms; Structure-Activity Relationship | 2013 |
Synthesis and antitumor activity of daunorubicin conjugates with of 3,4-methylendioxybenzaldehyde.
Topics: Antibiotics, Antineoplastic; Benzaldehydes; Cell Proliferation; Daunorubicin; Humans; Neoplasms; Tumor Cells, Cultured | 2019 |
Inhibition of Caco-2 and MCF-7 cancer cells using chalcones: synthesis, biological evaluation and computational study.
Topics: Antineoplastic Agents; Caco-2 Cells; Cell Proliferation; Chalcone; Chalcones; Daunorubicin; Humans; MCF-7 Cells; Molecular Structure; Neoplasms; Structure-Activity Relationship | 2022 |
Heterocyclic Compounds: Importance in Anticancer Drug Discovery.
Topics: Antineoplastic Agents; Daunorubicin; Doxorubicin; Fluorouracil; Heterocyclic Compounds; Humans; Methotrexate; Neoplasms; Pharmaceutical Preparations; Vinblastine; Vincristine | 2022 |
Comparative study on ABCB1-dependent efflux of anthracyclines and their metabolites: consequences for cancer resistance.
Topics: Adenosine Triphosphatases; Anthracyclines; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Daunorubicin; Doxorubicin; Humans; Neoplasms | 2023 |
Thioredoxin Decreases Anthracycline Cardiotoxicity, But Sensitizes Cancer Cell Apoptosis.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cardiotoxicity; Daunorubicin; HCT116 Cells; Humans; MCF-7 Cells; Myocytes, Cardiac; Neoplasms; Poly(ADP-ribose) Polymerases; Rats; Thioredoxins; Tumor Suppressor Protein p53; U937 Cells | 2021 |
Nucleic acid biohybrid nanocarriers with high-therapeutic payload and controllable extended release of daunomycin for cancer therapy.
Topics: Antibiotics, Antineoplastic; Aptamers, Nucleotide; Cell Survival; Daunorubicin; Delayed-Action Preparations; DNA; Drug Delivery Systems; Drug Liberation; Humans; MCF-7 Cells; Neoplasms | 2021 |
Cancer-Targeted Controlled Delivery of Chemotherapeutic Anthracycline Derivatives Using Apoferritin Nanocage Carriers.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Apoferritins; Cell Line, Tumor; Daunorubicin; Delayed-Action Preparations; Doxorubicin; Drug Delivery Systems; Epirubicin; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Nanostructures; Neoplasms | 2021 |
ABC-transporter blockage mediated by xanthotoxin and bergapten is the major pathway for chemosensitization of multidrug-resistant cancer cells.
Topics: 5-Methoxypsoralen; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Proliferation; Cell Survival; Cisplatin; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Kinetics; MCF-7 Cells; Methoxsalen; Mitoxantrone; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Neoplasms | 2017 |
Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
Topics: Adolescent; Adult; Anthracyclines; Antibiotics, Antineoplastic; Cancer Survivors; Cardiotoxicity; Child; Child, Preschool; Daunorubicin; Doxorubicin; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; Neoplasms; Prospective Studies; Ventricular Dysfunction, Left; Young Adult | 2018 |
Calcium carbonate end-capped, folate-mediated Fe
Topics: A549 Cells; Antibiotics, Antineoplastic; Calcium Carbonate; Daunorubicin; Delayed-Action Preparations; Drug Delivery Systems; Folate Receptors, GPI-Anchored; Folic Acid; HeLa Cells; Humans; Magnetite Nanoparticles; Neoplasms; Silicon Dioxide | 2018 |
Metal-free salan-type compound induces apoptosis and overcomes multidrug resistance in leukemic and lymphoma cells in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Leukemia; Lymphoma; Neoplasms; Phenylenediamines; Salicylates; Vincristine | 2018 |
Optimization of LC method for the quantification of doxorubicin in plasma and urine samples in view of pharmacokinetic, biomedical and drug monitoring therapy studies.
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Daunorubicin; Doxorubicin; Drug Monitoring; Etoposide; Fluorescence; Humans; Limit of Detection; Male; Neoplasms; Occupational Exposure; Personnel, Hospital; Prednisone; Reproducibility of Results; Solid Phase Extraction; Vincristine | 2018 |
Novel oxazolinoanthracyclines as tumor cell growth inhibitors-Contribution of autophagy and apoptosis in solid tumor cells death.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Daunorubicin; Doxorubicin; Growth Inhibitors; Humans; Membrane Potential, Mitochondrial; Neoplasms; Oxazoles; Reactive Oxygen Species | 2018 |
Development of multi-layered and multi-sensitive polymeric nanocontainers for cancer therapy: in vitro evaluation.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Daunorubicin; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Drug Liberation; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Nanostructures; Neoplasms; Polymers; Temperature; Tumor Microenvironment | 2018 |
Electrochemical, spectroscopic and theoretical monitoring of anthracyclines' interactions with DNA and ascorbic acid by adopting two routes: Cancer cell line studies.
Topics: Antibiotics, Antineoplastic; Antioxidants; Ascorbic Acid; Cardiotoxicity; Cell Line, Tumor; Cell Proliferation; Daunorubicin; DNA; Doxorubicin; Drug Interactions; Epirubicin; Humans; Hydrogen-Ion Concentration; Molecular Docking Simulation; Neoplasms | 2018 |
Effect of coumarin derivative-mediated inhibition of P-glycoprotein on oral bioavailability and therapeutic efficacy of paclitaxel.
Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cell Line, Tumor; Cell Survival; Coumarins; Daunorubicin; Humans; Male; Mice; Mice, Nude; Neoplasms; Paclitaxel; Rats; Rats, Sprague-Dawley; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
The effect of photoimmunotherapy followed by liposomal daunorubicin in a mixed tumor model: a demonstration of the super-enhanced permeability and retention effect after photoimmunotherapy.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; BALB 3T3 Cells; Cell Line, Tumor; Coculture Techniques; Daunorubicin; ErbB Receptors; Female; Fluorescent Dyes; Humans; Immunotherapy; Light; Liposomes; Mice; Mice, Nude; Neoplasms; Panitumumab; Photochemotherapy; Photosensitizing Agents; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Interindividual variability in the cardiac expression of anthracycline reductases in donors with and without Down syndrome.
Topics: 3-Hydroxysteroid Dehydrogenases; Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductase Family 1 Member C3; Anthracyclines; Cardiotoxins; Daunorubicin; Down Syndrome; Female; Gene Expression; Genotype; Heart; Humans; Hydroxyprostaglandin Dehydrogenases; Male; Myocardium; Neoplasms; RNA, Messenger | 2014 |
pH- and thermo-responsive microcontainers as potential drug delivery systems: Morphological characteristic, release and cytotoxicity studies.
Topics: 3T3 Cells; Acrylic Resins; Animals; Antineoplastic Agents; Cell Survival; Daunorubicin; Drug Carriers; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Mice; Nanoparticles; Neoplasms; Particle Size; Polymers; Polymethyl Methacrylate; Styrenes; Temperature | 2014 |
Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology Group.
Topics: Absorptiometry, Photon; Antibiotics, Antineoplastic; Body Composition; Body Mass Index; Child; Daunorubicin; Drug Screening Assays, Antitumor; Female; Genome-Wide Association Study; Glutathione S-Transferase pi; Haplotypes; Humans; Male; Metabolic Clearance Rate; Models, Statistical; Neoplasms; Obesity; Oxygenases; Pharmacogenetics; Polymorphism, Genetic | 2014 |
Curcumin is a tight-binding inhibitor of the most efficient human daunorubicin reductase--Carbonyl reductase 1.
Topics: Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Curcumin; Daunorubicin; Humans; NADP; Neoplasms | 2015 |
Chemical profiling of the genome with anti-cancer drugs defines target specificities.
Topics: Aclarubicin; Antineoplastic Agents; Cell Line, Tumor; Chromatin; Daunorubicin; DNA Damage; DNA, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Genome, Human; Histones; Humans; Molecular Targeted Therapy; Neoplasms; Organ Specificity; Protein Transport; Structure-Activity Relationship; Topoisomerase Inhibitors; Topotecan | 2015 |
[The study of mechanisms of accumulation of daunorubicin and rodamin-123 in cells of human venous blood using cytometry technique].
Topics: Blood Platelets; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Healthy Volunteers; Humans; Leukocytes; Neoplasms; Rhodamine 123 | 2015 |
Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.
Topics: Adolescent; Adult; Anthracyclines; Antibiotics, Antineoplastic; Cardiotoxins; Child; Child, Preschool; Daunorubicin; Doxorubicin; Female; Heart Failure; Humans; Infant; Male; Neoplasms; Odds Ratio; Survivors; Therapeutic Equivalency; Young Adult | 2015 |
Real-Time Evaluation of Live Cancer Cells by an in Situ Surface Plasmon Resonance and Electrochemical Study.
Topics: Adsorption; Antineoplastic Agents; Apoptosis; Cell Adhesion; Cell Survival; Culture Media; Daunorubicin; Drug Screening Assays, Antitumor; Electrochemistry; Hep G2 Cells; Humans; Microscopy; Neoplasms; Oligonucleotide Array Sequence Analysis; Refractometry; Surface Plasmon Resonance; Tetrazolium Salts | 2015 |
Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment.
Topics: Aldehyde Reductase; Aldo-Keto Reductases; Apigenin; Daunorubicin; Enzyme Inhibitors; Flavones; Flavonoids; HCT116 Cells; Humans; Luteolin; Molecular Conformation; Molecular Structure; Neoplasms | 2015 |
PRX1 knockdown potentiates vitamin K3 toxicity in cancer cells: a potential new therapeutic perspective for an old drug.
Topics: Antineoplastic Agents; Dactinomycin; Daunorubicin; Doxorubicin; Fluorouracil; Gene Knockdown Techniques; HeLa Cells; Homeodomain Proteins; Humans; Neoplasms; Paclitaxel; Reactive Oxygen Species; Vinblastine; Vitamin K 3 | 2015 |
The daunorubicin interplay with mimetic model membranes of cancer cells: A biophysical interpretation.
Topics: Anisotropy; Antibiotics, Antineoplastic; Biophysics; Daunorubicin; Fluorescent Dyes; Hydrogen-Ion Concentration; Light; Lipid Bilayers; Membrane Fluidity; Neoplasms; Scattering, Radiation | 2017 |
The incorporation of daunorubicin in cancer cells through the use of titanium dioxide whiskers.
Topics: Catalysis; Cell Death; Cell Line, Tumor; Daunorubicin; Drug Carriers; Flow Cytometry; Humans; Intracellular Space; Light; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Models, Biological; Neoplasms; Solutions; Spectrophotometry, Ultraviolet; Titanium | 2009 |
Electroporation and alternating current cause membrane permeation of photodynamic cytotoxins yielding necrosis and apoptosis of cancer cells.
Topics: Animals; Apoptosis; Cell Death; Cell Line, Tumor; Cell Membrane Permeability; Cytotoxins; Dactinomycin; Daunorubicin; Electrochemotherapy; Electromagnetic Fields; Electroporation; Humans; Leukemia, Erythroblastic, Acute; Lymphoma; Necrosis; Neoplasms; Photochemotherapy; Time Factors | 2010 |
Triggering liposomal drug release with a lysosomotropic agent.
Topics: Animals; Antibiotics, Antineoplastic; Arylsulfonates; Cell Line, Tumor; Chloroquine; Daunorubicin; Female; Folic Acid; Humans; Hydrogen-Ion Concentration; Leukemia L1210; Liposomes; Lysosomes; Mice; Mice, Inbred DBA; Microscopy, Confocal; Neoplasms | 2010 |
Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity?
Topics: Adult; Anthracyclines; Antibiotics, Antineoplastic; Cardiomyopathy, Dilated; Cardiotoxins; Daunorubicin; Doxorubicin; Genetic Predisposition to Disease; Humans; Male; Neoplasms; Risk Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2010 |
Design, synthesis, in vitro stability and cytostatic effect of multifunctional anticancer drug-bioconjugates containing GnRH-III as a targeting moiety.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Daunorubicin; Humans; Neoplasms | 2012 |
Copy number polymorphisms and anticancer pharmacogenomics.
Topics: Antineoplastic Agents; Biomarkers, Pharmacological; Carboplatin; Cell Line, Tumor; Cisplatin; Daunorubicin; Etoposide; Gene Dosage; Gene Expression; Genetic Predisposition to Disease; Genetic Variation; Genome-Wide Association Study; Genome, Human; Humans; Inhibitory Concentration 50; Neoplasms; Oligonucleotide Array Sequence Analysis; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Quantitative Trait Loci; Topoisomerase II Inhibitors | 2011 |
Enhanced enzymatic stability and antitumor activity of daunorubicin-GnRH-III bioconjugates modified in position 4.
Topics: Amino Acid Sequence; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Daunorubicin; Drug Stability; Female; Gonadotropin-Releasing Hormone; Humans; Lysosomes; Mice; Mice, Inbred BALB C; Neoplasms; Protein Structure, Secondary; Pyrrolidonecarboxylic Acid; Rats; Serum | 2011 |
Structure-activity relationship and molecular mechanisms of ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017) and its analogues.
Topics: Antineoplastic Agents; Benzopyrans; Cell Line, Tumor; Cell Survival; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; HCT116 Cells; HL-60 Cells; HT29 Cells; Humans; Inhibitory Concentration 50; K562 Cells; Mitoxantrone; Molecular Structure; Neoplasms; Paclitaxel; Stereoisomerism; Structure-Activity Relationship; Vincristine | 2011 |
A new daunomycin-peptide conjugate: synthesis, characterization and the effect on the protein expression profile of HL-60 cells in vitro.
Topics: Amino Acid Sequence; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Membrane Permeability; Cytostatic Agents; Daunorubicin; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Neoplasms; Peptides; Receptor, ErbB-2 | 2011 |
Autophagy inhibition enhances daunorubicin-induced apoptosis in K562 cells.
Topics: Antibiotics, Antineoplastic; Antirheumatic Agents; Apoptosis; Autophagy; Chloroquine; Daunorubicin; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Humans; K562 Cells; Leukemia, Myeloid; Microscopy, Confocal; Microscopy, Electron, Transmission; Neoplasms; RNA, Small Interfering; Signal Transduction | 2011 |
Synthesis and characterization of G5 PAMAM dendrimer containing daunorubicin for targeting cancer cells.
Topics: Daunorubicin; Dendrimers; Drug Carriers; Folic Acid; Humans; Molecular Structure; Neoplasms | 2012 |
Synthesis and biological activities of a 3'-azido analogue of Doxorubicin against drug-resistant cancer cells.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Cell Line, Tumor; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Male; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Molecular; Molecular Docking Simulation; Neoplasms; Xenograft Model Antitumor Assays | 2012 |
[High-density lipoproteins as a form of daunorubicin transport in hepatoma cells of mice].
Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Cell Line, Tumor; Daunorubicin; Drug Carriers; Lipoproteins, HDL; Mice; Neoplasms; Rats | 2012 |
Inhibition of tumor growth in vitro by the extract of fagopyrum cymosum (fago-c).
Topics: Antineoplastic Agents, Phytogenic; Cell Division; Chromatography, High Pressure Liquid; Daunorubicin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Drugs, Chinese Herbal; Electrophoresis, Gel, Two-Dimensional; Female; Humans; Male; Neoplasms; Plant Extracts; Tumor Cells, Cultured | 2003 |
The late consequences of anthracycline treatment on left ventricular function after treatment for childhood cancer.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Child; Child, Preschool; Daunorubicin; Doxorubicin; Female; Humans; Male; Neoplasms; Regression Analysis; Remission Induction; Ventricular Function, Left | 2003 |
[A NEW ANTIBIOTIC WITH CYTOSTATIC PROPERTIES: RUBIDOMYCIN].
Topics: Adenocarcinoma; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Benzopyrenes; Carcinoma, Ehrlich Tumor; Daunorubicin; Leukemia; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mice; Neoplasms; Research; Sarcoma 180; Sarcoma, Experimental; Streptomyces; Toxicology | 1963 |
DAUNOMYCIN: A NEW ANTIBIOTIC WITH ANTITUMOR ACTIVITY.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Daunorubicin; Liver Neoplasms; Mice; Neoplasms; Neoplasms, Experimental; Pathology; Pharmacology; Rats; Research; Sarcoma 180; Toxicology | 1964 |
ACTIVITY OF DAUNOMYCIN, A NEW ANTITUMOR ANTIBIOTIC, ON NORMAL AND NEOPLASTIC CELLS GROWN IN VITRO.
Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antibiotics, Antitubercular; Antineoplastic Agents; Bone Marrow; Carcinoma 256, Walker; Daunorubicin; Fibroblasts; In Vitro Techniques; Mice; Neoplasms; Neoplasms, Experimental; Pathology; Rats; Research; RNA; Tissue Culture Techniques | 1964 |
RUBIDOMYCIN: A NEW ANTIBIOTIC WITH CYTOSTATIC PROPERTIES.
Topics: Animals; Anti-Bacterial Agents; Carcinoma, Ehrlich Tumor; Daunorubicin; Leukemia; Leukemia, Experimental; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mice; Neoplasms; Neoplasms, Experimental; Pathology; Research; Sarcoma 180; Sarcoma, Experimental; Toxicology | 1964 |
Dynamic and intracellular trafficking of P-glycoprotein-EGFP fusion protein: Implications in multidrug resistance in cancer.
Topics: Antibiotics, Antineoplastic; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brefeldin A; Cell Membrane; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endoplasmic Reticulum; Golgi Apparatus; Green Fluorescent Proteins; HeLa Cells; Humans; Luminescent Proteins; Microscopy, Confocal; Monensin; Neoplasms; Protein Transport; Recombinant Fusion Proteins | 2004 |
[Inhibition of tumor growth in vitro by the extract of Fagopyrum cymosum].
Topics: Antibiotics, Antineoplastic; Cell Proliferation; Chromatography, High Pressure Liquid; Daunorubicin; Drugs, Chinese Herbal; Electrophoresis, Gel, Two-Dimensional; Female; Herb-Drug Interactions; Humans; Male; Neoplasms; Plant Extracts; Polygonaceae; Tumor Cells, Cultured | 2003 |
Immune thrombocytopenia following successful treatment of cancer in children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Cells; Carmustine; Child, Preschool; Cyclophosphamide; Daunorubicin; Etoposide; Female; Humans; Infant; Male; Neoplasms; Platelet Count; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Vincristine | 2006 |
Schisandrin B--a novel inhibitor of P-glycoprotein.
Topics: Affinity Labels; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Cell Line, Tumor; Cell Proliferation; Cyclooctanes; Daunorubicin; Dihydropyridines; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Humans; Inhibitory Concentration 50; K562 Cells; Lignans; Models, Chemical; Neoplasms; Polycyclic Compounds; Protein Binding; Tetrazolium Salts; Thiazoles; Time Factors | 2005 |
Anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study.
Topics: Adolescent; Adult; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brachial Artery; Case-Control Studies; Child; Child, Preschool; Coronary Artery Disease; Daunorubicin; Doxorubicin; Endothelium, Vascular; Female; Humans; Male; Neoplasms; Pilot Projects; Ultrasonography | 2006 |
Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Multidrug Resistance-Associated Proteins; Neoplasms; Phenotype; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Verapamil | 2006 |
Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Cisplatin; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Synergism; Floxuridine; Humans; Irinotecan; Liposomes; Mice; Neoplasms; Xenograft Model Antitumor Assays | 2006 |
Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia.
Topics: Apoptosis; Cell Hypoxia; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Glucose; Glucose Transport Proteins, Facilitative; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Neoplasms; Phloretin | 2007 |
A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapy.
Topics: Cell Line, Tumor; Daunorubicin; DNA; DNA Fragmentation; Humans; Iodine Radioisotopes; Neoplasms; Radiopharmaceuticals; Tissue Distribution | 2006 |
Acute cardiac functional and morphological changes after Anthracycline infusions in children.
Topics: Adolescent; Anthracyclines; Antibiotics, Antineoplastic; Blood Flow Velocity; Blood Pressure; Child; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Echocardiography, Doppler; Female; Heart Rate; Humans; Idarubicin; Infusions, Intravenous; Male; Myocardial Contraction; Neoplasms; Observer Variation; Prospective Studies; Reproducibility of Results; Research Design; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2007 |
Upregulation of Twist-1 by NF-kappaB blocks cytotoxicity induced by chemotherapeutic drugs.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line; Cell Survival; Cyclin-Dependent Kinase Inhibitor p16; Daunorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation; Humans; Neoplasms; NF-kappa B; Nuclear Proteins; Proto-Oncogene Proteins c-bcl-2; Repressor Proteins; Signal Transduction; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Twist-Related Protein 1; Up-Regulation | 2007 |
Cardiac troponin T following anthracycline chemotherapy in children and adolescents.
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Daunorubicin; Doxorubicin; Humans; Infant; Neoplasms; Troponin T | 2007 |
Impact of hypoxic and acidic extracellular conditions on cytotoxicity of chemotherapeutic drugs.
Topics: Acidosis; Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Daunorubicin; Docetaxel; Extracellular Space; Humans; Hydrogen-Ion Concentration; Hypoxia; Neoplasms; Rats; Taxoids | 2007 |
Late echocardiography assessment of systolic and diastolic function of the left ventricle in pediatric cancer survivors after anthracycline therapy.
Topics: Adolescent; Adult; Anthracyclines; Antineoplastic Agents; Daunorubicin; Diastole; Doxorubicin; Echocardiography; Female; Humans; Male; Neoplasms; Systole; Ventricular Dysfunction, Left | 2007 |
Effect of surface chemistry modification of functional gold nanoparticles on the drug accumulation of cancer cells.
Topics: 3-Mercaptopropionic Acid; Cell Proliferation; Daunorubicin; Drug Resistance, Neoplasm; Fluorescence; Gold; Humans; K562 Cells; Microscopy, Confocal; Nanoparticles; Neoplasms; Surface Properties | 2008 |
Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancers.
Topics: Aldehyde Reductase; Aldo-Keto Reductases; Antibiotics, Antineoplastic; Antineoplastic Agents; Benzothiazoles; Clofibric Acid; Cysteine; Daunorubicin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyceraldehyde; Humans; Imidazolidines; Kinetics; Mutation; Neoplasms; Oxidation-Reduction; Phthalazines; Pyrimidines; Recombinant Proteins; Serine | 2008 |
Genetic variants contributing to daunorubicin-induced cytotoxicity.
Topics: Antibiotics, Antineoplastic; Aryl Hydrocarbon Hydroxylases; Cell Line, Tumor; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme System; Daunorubicin; Drug Resistance, Neoplasm; Genetic Linkage; Genetic Predisposition to Disease; Genotype; Humans; Inhibitory Concentration 50; Neoplasms; Polymorphism, Single Nucleotide | 2008 |
Sister chromatid exchange in childhood malignancies.
Topics: Antineoplastic Agents; Cells, Cultured; Child; Crossing Over, Genetic; Cyclophosphamide; Daunorubicin; Humans; Leukemia, Lymphoid; Lymphocytes; Methotrexate; Neoplasms; Sister Chromatid Exchange; Vincristine | 1983 |
Preparation of four daunomycin-monoclonal antibody 791T/36 conjugates with anti-tumour activity.
Topics: Animals; Antibodies, Monoclonal; Carrier Proteins; Cell Line; Chemical Phenomena; Chemistry; Daunorubicin; Flow Cytometry; Fluorescent Antibody Technique; Humans; Mice; Neoplasms | 1984 |
The heterogeneity of the interaction between cancer chemotherapeutic agents and host resistance mechanisms.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Doxorubicin; Immunity; Immunosuppression Therapy; Killer Cells, Natural; Macrophages; Neoplasms; T-Lymphocytes, Regulatory | 1980 |
Pharmacology and phase I clinical studies of daunorubicin in patients with advanced malignancies.
Topics: Adult; Aged; Daunorubicin; Drug Evaluation; Female; Humans; Kinetics; Male; Middle Aged; Neoplasms | 1984 |
Use of daunorubicin in patients with solid tumors.
Topics: Calcium Channel Blockers; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Neoplasms; Ricin; Trifluoperazine; Tumor Stem Cell Assay | 1984 |
A phase I study of daunorubicin in advanced untreatable malignancies.
Topics: Adult; Aged; Blood; Daunorubicin; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms | 1984 |
Clinical pharmacology of daunorubicin in phase I patients with solid tumors: development of an analytical methodology for daunorubicin and its metabolites.
Topics: Animals; Bile; Chromatography, High Pressure Liquid; Daunorubicin; Drug Evaluation; Humans; Kinetics; Neoplasms; Rats; Rats, Inbred Strains | 1984 |
Clinical and morphologic cardiac findings after anthracycline chemotherapy. Analysis of 64 patients studied at necropsy.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Autopsy; Child; Child, Preschool; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Electrocardiography; Female; Heart; Humans; Male; Middle Aged; Myocardium; Naphthacenes; Neoplasms | 1983 |
Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Immunosuppression Therapy; Injections, Intravenous; Kinetics; Male; Middle Aged; Neoplasms | 1983 |
Phase I study of 4-demethoxydaunorubicin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Child; Child, Preschool; Daunorubicin; Digestive System; Drug Evaluation; Female; Humans; Idarubicin; Injections, Intravenous; Leukopenia; Male; Middle Aged; Neoplasms; Thrombocytopenia | 1983 |
Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral doses.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Biological Availability; Blood; Daunorubicin; Drug Evaluation; Female; Heart; Humans; Idarubicin; Male; Middle Aged; Neoplasms | 1984 |
Toxicity of anticancer drugs used in children.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Child; Child, Preschool; Cisplatin; Daunorubicin; Doxorubicin; Humans; Methotrexate; Neoplasms; Teniposide | 1980 |
New anthracycline antibiotic aclacinomycin A: experimental studies and correlations with clinical trials.
Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Cricetinae; Daunorubicin; Dogs; Doxorubicin; Drug Evaluation; Drug Evaluation, Preclinical; Female; Humans; In Vitro Techniques; Male; Mice; Naphthacenes; Neoplasms; Neoplasms, Experimental; Rabbits; Rats | 1981 |
Recovery of left ventricular function following discontinuation of anthracycline chemotherapy in children.
Topics: Adolescent; Antibiotics, Antineoplastic; Child; Child, Preschool; Daunorubicin; Doxorubicin; Echocardiography; Glycosides; Heart Rate; Heart Ventricles; Humans; Infant; Naphthacenes; Neoplasms | 1981 |
Phase I trial of 4-demethoxydaunorubicin with single i.v. doses.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Diseases; Daunorubicin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Humans; Idarubicin; Kinetics; Male; Middle Aged; Neoplasms | 1982 |
The cardiotoxicity of anticancer agents.
Topics: Antineoplastic Agents; Cardiomyopathies; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Electrocardiography; Heart; Heart Diseases; Heart Failure; Humans; Neoplasms | 1982 |
A phase I and clinical pharmacology study of intravenously administered carminomycin in cancer patients in the United States.
Topics: Adult; Aged; Agranulocytosis; Carubicin; Colony-Forming Units Assay; Daunorubicin; Drug Evaluation; Female; Heart Diseases; Humans; Infusions, Parenteral; Male; Middle Aged; Neoplasms | 1982 |
Non-invasive evaluation of anthracycline-induced cardiotoxicity in man.
Topics: Adolescent; Adult; Aged; Daunorubicin; Doxorubicin; Echocardiography; Female; Humans; Male; Middle Aged; Neoplasms; Radiography; Systole; Tachycardia | 1982 |
Drug targeting in cancer treatment: active daunorubicin-protein conjugates.
Topics: Animals; Daunorubicin; Female; Humans; Kinetics; Lysosomes; Mice; Mice, Inbred DBA; Neoplasms; Protein Binding; Serum Albumin, Bovine | 1982 |
Carminomycin (NSC-180024): a phase I study.
Topics: Adult; Aged; Carubicin; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Thrombocytopenia | 1980 |
Available data from carminomycin studies in the United States: the acute intermittent intravenous schedule.
Topics: Adolescent; Adult; Aged; Carubicin; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Humans; Injections, Intravenous; Leukopenia; Middle Aged; Neoplasms; United States | 1981 |
Analysis of carminomycin in human serum by fluorometric high-performance liquid chromatography.
Topics: Analysis of Variance; Carubicin; Chromatography, High Pressure Liquid; Daunorubicin; Humans; Injections, Intravenous; Neoplasms; Reference Standards; Time Factors | 1981 |
Preliminary results of a phase II trial on solid tumors of detorubicin, a new anthracyclin.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Melanoma; Middle Aged; Neoplasms; Uterine Neoplasms | 1980 |
Experimental and clinical activity of a new anthracycline derivative: detorubicin (14-diethoxyacetoxydaunorubicin).
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Daunorubicin; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Mice; Mutagens; Neoplasms; Neoplasms, Experimental | 1980 |
Clinical study of detorubicin. EORTC Clinical Screening Group.
Topics: Antibiotics, Antineoplastic; Daunorubicin; Drug Evaluation; Humans; Neoplasms | 1980 |
[The significance of preventive CNS irradiation during antineoplastic therapy in childhood with regard to late odontogenic and mandibulofacial injuries].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cephalometry; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Daunorubicin; Female; Humans; Infant; Male; Maxillofacial Development; Neoplasms; Odontogenesis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Radiation Injuries; Radiotherapy Dosage; Time Factors; Vincristine | 1995 |
Heart transplantation is a valid therapeutic option for anthracycline cardiomyopathy.
Topics: Actuarial Analysis; Adult; Azathioprine; Cardiomyopathies; Cyclosporine; Daunorubicin; Doxorubicin; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Male; Neoplasms; Prednisolone; Survival Rate | 1995 |
Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenografts.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Doxorubicin; Drug Resistance; Female; Flow Cytometry; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Nucleotides; Ribonucleases; Vincristine | 1995 |
[Use of cyclosporin and verapamil in association with chemotherapy in the treatment of pediatric patients with advanced-stage neoplasms. A pilot study].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cyclosporins; Daunorubicin; Doxorubicin; Drug Resistance; Female; Humans; Male; Medulloblastoma; Neoplasms; Neuroblastoma; Osteosarcoma; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Verapamil; Vincristine | 1994 |
Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.
Topics: Alkaloids; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carrier Proteins; Daunorubicin; Doxorubicin; Drug Resistance; Etoposide; Genistein; Humans; Hydrogen-Ion Concentration; Isoflavones; Lung Neoplasms; Membrane Glycoproteins; Neoplasms; Protein-Tyrosine Kinases; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1993 |
Fluorometric determination of the kinetics of anthracyclines uptake by cells.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Culture Media; Daunorubicin; Doxorubicin; Epithelial Cells; Epithelium; Extracellular Space; Fluorometry; Lipoproteins, LDL; Lung Neoplasms; Neoplasms; Rats; Spectrometry, Fluorescence; Thyroid Gland; Thyroid Neoplasms | 1994 |
Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiation.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Child; Child, Preschool; Combined Modality Therapy; Daunorubicin; Doxorubicin; Female; Follow-Up Studies; Heart; Heart Diseases; Humans; Male; Neoplasms; Radiation Injuries; Radiotherapy | 1996 |
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Nucleus; Cycloheximide; Daunorubicin; DNA-Binding Proteins; Humans; I-kappa B Proteins; Interleukin-1; Leupeptins; Neoplasms; NF-kappa B; NF-KappaB Inhibitor alpha; Protein Synthesis Inhibitors; Radiation, Ionizing; Staurosporine; Transcription Factor RelA; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
Echocardiographic evaluation of cardiac function in paediatric oncology patients treated with or without anthracycline.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Diastole; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Echocardiography, Doppler; Female; Heart; Heart Ventricles; Humans; Male; Neoplasms; Retrospective Studies; Systole; Ventricular Dysfunction, Left | 1997 |
Daunorubicin cardiotoxicity in childhood cancer.
Topics: Adult; Aging; Animals; Antibiotics, Antineoplastic; Child, Preschool; Daunorubicin; Heart; Humans; Mice; Neoplasms | 1998 |
Synthesis of 4'-epi-iodo-4'-deoxy-daunorubicin, a potential cancer radiotherapeutic agent.
Topics: Antibiotics, Antineoplastic; Daunorubicin; Intercalating Agents; Iodine Radioisotopes; Neoplasms | 1998 |
A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain Chemistry; Calcium Channel Blockers; Carcinoma, Small Cell; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms; Rats; Rats, Nude; Recombinant Fusion Proteins; Tissue Distribution; Tumor Cells, Cultured; Verapamil | 1999 |
Cytostatic drug resistance. Role of phase-I daunorubicin metabolism in cancer cells.
Topics: Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; Antibiotics, Antineoplastic; Daunorubicin; Drug Resistance, Neoplasm; Humans; Neoplasms; Stomach Neoplasms; Transfection; Tumor Cells, Cultured | 1999 |
Alterations in the expression of daunorubicin phase-I metabolising enzymes in different carcinoma cell lines.
Topics: Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; Antibiotics, Antineoplastic; Daunorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Enzymologic; Humans; Neoplasms; Oxidoreductases; Pancreatic Neoplasms; Tumor Cells, Cultured | 1999 |
Re: The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Carbazoles; Daunorubicin; Enzyme Inhibitors; Genes, ras; Humans; Neoplasms; Pyridines; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1999 |
Late effects of anthracycline therapy in childhood on signal-averaged ECG parameters.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Daunorubicin; Disease-Free Survival; Doxorubicin; Electrocardiography; Female; Heart; Heart Diseases; Humans; Male; Neoplasms | 2000 |
Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Daunorubicin; Docetaxel; Drug Resistance, Multiple; Feces; Half-Life; Humans; Intestinal Mucosa; Metabolic Clearance Rate; Mixed Function Oxygenases; Neoplasms; Paclitaxel; Quinolines; Taxoids; Tumor Cells, Cultured | 2000 |
NeXstar Pharmaceuticals lauches DaunoXome.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Drug Approval; Drug Carriers; Humans; Liposomes; Neoplasms; United States; United States Food and Drug Administration | 1996 |
Elevation of glucosylceramide in multidrug-resistant cancer cells and accumulation in cytoplasmic droplets.
Topics: Cell Nucleus; Cytoplasm; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glucosylceramides; Humans; Inositol; Microscopy, Confocal; Neoplasms; Tumor Cells, Cultured | 2001 |
Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Cell Survival; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Genes, MDR; Humans; Indicators and Reagents; Neoplasms; Poly A; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Vinblastine | 2002 |
Human growth hormone gene transfer into tumor cells may improve cancer chemotherapy.
Topics: Antibiotics, Antineoplastic; Body Weight; Cell Death; Cell Nucleus; Combined Modality Therapy; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; Gene Transfer Techniques; Human Growth Hormone; Humans; Neoplasms; NF-kappa B; Time Factors; Transfection; Tumor Cells, Cultured; U937 Cells | 2002 |
The International Symposium on the Clinical and Pharmacological Effects of the Daunorubicin-DNA Complex. Huddinge University Hospital, Stockholm, Sweden, March 17, 1978. Proceedings.
Topics: Congresses as Topic; Daunorubicin; DNA; Humans; Neoplasms; Sweden | 1979 |
Letter: Mitochondria in oncogenesis.
Topics: Acriflavine; Animals; Bromides; Carcinogens; Cell Membrane; Cell Transformation, Neoplastic; Daunorubicin; DNA, Mitochondrial; Ethidium; Humans; Mitochondria; Mitosis; Mutation; Neoplasms; Transcription, Genetic | 1975 |
Lower plants as a source of anticancer drugs.
Topics: Actinomycetales; Antibiotics, Antineoplastic; Bleomycin; Chemical Phenomena; Chemistry; Dactinomycin; Daunorubicin; Drug Evaluation, Preclinical; Fermentation; Humans; National Institutes of Health (U.S.); Neoplasms; Plicamycin; Sterigmatocystin; Streptomyces; United States | 1976 |
Clinical pharmacology of anticancer drugs.
Topics: Animals; Antineoplastic Agents; Azacitidine; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Doxorubicin; Female; Fluorouracil; Heart; Humans; Leucovorin; Lung; Male; Methotrexate; Neoplasms; Nitrosourea Compounds; Procarbazine; Triazenes; Vinblastine; Vincristine | 1977 |
Recent advances in antitumor antibiotics.
Topics: Aclarubicin; Animals; Anthraquinones; Antibiotics, Antineoplastic; Bleomycin; Daunorubicin; DNA; Glycosides; Humans; Neoplasms; Structure-Activity Relationship; Zinostatin | 1978 |
Sensitivity tests of tumors to cytostatic agents. II. Investigation on human tumors.
Topics: Antineoplastic Agents; Autoradiography; Breast Neoplasms; Cell Count; Cell Division; Culture Techniques; Dactinomycin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Neoplasms; Nucleic Acids; Ovarian Neoplasms; Procarbazine; Uridine | 1975 |
Childhood cancer: the improving prognosis.
Topics: Asparaginase; Child; Cyclophosphamide; Cytosine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Infant; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Melphalan; Mercaptopurine; Methotrexate; Neoplasms; Nitrogen Mustard Compounds; Osteosarcoma; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous; Rhabdomyosarcoma; Teniposide; Thioguanine; Vincristine; Wilms Tumor | 1976 |
Some new aspects of modern cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Survival; Daunorubicin; Drug Therapy, Combination; Humans; Kinetics; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid; Methotrexate; Mitosis; Neoplasms; Neuraminidase; Prednisone; Vincristine | 1977 |
Phase 1 trial and assay of rubidazone (NSC 164011) in patients with advanced solid tumors.
Topics: Adult; Chromatography, High Pressure Liquid; Daunorubicin; Drug Evaluation; Female; Humans; Infusions, Parenteral; Leukopenia; Male; Middle Aged; Neoplasms; Time Factors | 1979 |
Clinical activity of detorubicin: a new anthracycline derivative.
Topics: Acute Disease; Animals; Daunorubicin; Doxorubicin; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Leukemia; Mice; Neoplasms; Neoplasms, Experimental | 1979 |
[Detorubicin (33 921 R.P.): medullary tolerance (author's transl)].
Topics: Adult; Aged; Blood Cells; Blood Platelets; Daunorubicin; Dose-Response Relationship, Drug; Female; Humans; Leukocytes; Male; Middle Aged; Neoplasms | 1979 |
A survey of the anthracycline derivatives in hematology.
Topics: Anthracenes; Antineoplastic Agents; Daunorubicin; DNA; Doxorubicin; Humans; Immunosuppressive Agents; Kinetics; Neoplasms; RNA | 1979 |
Daunorubicin-DNA and doxorubicin-DNA. A review of experimental and clinical data.
Topics: Animals; Daunorubicin; DNA; Doxorubicin; Humans; Neoplasms | 1979 |
Echocardiographic assessment of anthracycline cardiotoxicity in children.
Topics: Adolescent; Adult; Child; Child, Preschool; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Echocardiography; Evaluation Studies as Topic; Heart; Heart Failure; Humans; Infant; Neoplasms | 1978 |
[Effects of various antibiotic agents on normal and cancerous cells].
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Ehrlich Tumor; Cells, Cultured; Dactinomycin; Daunorubicin; Mice; Mitosis; Neoplasms; Nogalamycin | 1975 |
[Cellular pathology].
Topics: Acid Phosphatase; Animals; Arteriosclerosis; Cholesterol; Daunorubicin; DNA; Ethidium; Heart; Humans; Hydrolases; Lysosomes; Mice; Muscles; Neoplasms; Parasitic Diseases; Pinocytosis; Rabbits; Subcellular Fractions; Trypanosoma cruzi; Trypanosomiasis | 1976 |
Plasma adriamycin and daunorubicin levels by fluorescence and radioimmunoassay.
Topics: Daunorubicin; Doxorubicin; Fluorometry; Humans; Kinetics; Methods; Neoplasms; Radioimmunoassay; Time Factors | 1977 |
Cellular effects of combined adriamycin and x-irradiation in human tumor cells.
Topics: Cell Line; Cell Survival; Daunorubicin; DNA Repair; DNA, Neoplasm; Dose-Response Relationship, Drug; Doxorubicin; HeLa Cells; Neoplasms; Plastics; Structure-Activity Relationship; X-Rays | 1977 |
Rapid assays for evaluating the drug sensitivity of tumor cells.
Topics: Antineoplastic Agents; Ascitic Fluid; Cell Division; Cell Line; Daunorubicin; DNA, Neoplasm; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance; Humans; In Vitro Techniques; Melphalan; Methotrexate; Neoplasms; Phenotype; Pleural Effusion; Puromycin; RNA, Neoplasm; Vinblastine | 1977 |
[Clinical problems of optimum bioavailability, in particular in cytostatic therapy (author's transl)].
Topics: Animals; Antineoplastic Agents; Biological Availability; Biopharmaceutics; Cytarabine; Daunorubicin; DNA; DNA Nucleotidyltransferases; DNA Replication; Dose-Response Relationship, Drug; Doxorubicin; Half-Life; Humans; Infusions, Parenteral; Kinetics; Mice; Mitosis; Models, Biological; Neoplasms; Rats; RNA; Sarcoma 180 | 1976 |
Activity of daunomycin in solid tumors.
Topics: Daunorubicin; Humans; Neoplasms | 1976 |
Alkali-labile regions and strand breaks in DNA from cells treated with daunorubicin.
Topics: Animals; Cells, Cultured; Centrifugation, Density Gradient; Daunorubicin; DNA; DNA Repair; DNA, Single-Stranded; Mice; Neoplasms; Sucrose; Thymidine | 1976 |
Experimentally developed cellular resistance to daunomycin. Resistance mechanisms, the daunomycin-pump and cross resistance to adriamycin, vincristine and vinblastine.
Topics: Animals; Daunorubicin; DNA, Neoplasm; Doxorubicin; Drug Resistance; Humans; Immunity, Cellular; Neoplasms; Neoplasms, Experimental; RNA, Neoplasm; Vinblastine; Vincristine | 1976 |
The cardiotoxicity of adriamycin and daunomycin in children.
Topics: Adolescent; Child; Daunorubicin; Digitalis Glycosides; Dose-Response Relationship, Drug; Doxorubicin; Electrocardiography; Heart Diseases; Heart Failure; Humans; Neoplasms | 1976 |
A discrepancy between the instantaneous and the overall collection efficiency of the Fenwal CS3000 for peripheral blood stem cell apheresis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Cells; Blood Component Removal; Blood Transfusion, Autologous; Bone Marrow Diseases; Cyclophosphamide; Cytarabine; Daunorubicin; Evaluation Studies as Topic; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Neoplasms; Thioguanine | 1992 |
Evaluation of a method for detection of cells with reduced drug retention in solid tumours.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Breast Neoplasms; Cell Survival; Chromatography, High Pressure Liquid; Culture Media; Cyclosporine; Daunorubicin; Drug Resistance; Female; Flow Cytometry; Friend murine leukemia virus; Humans; Hydrogen-Ion Concentration; Leukemia, Erythroblastic, Acute; Membrane Glycoproteins; Mice; Neoplasm Proteins; Neoplasms; Nephelometry and Turbidimetry; Reference Standards; Reproducibility of Results; Treatment Outcome; Tumor Cells, Cultured; Verapamil | 1992 |
Pneumonia and pneumonitis in childhood malignancy.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Child; Clinical Protocols; Daunorubicin; Humans; Immunocompromised Host; Leukemia; Methotrexate; Neoplasms; Opportunistic Infections; Pneumonia; Pneumonia, Viral; Prednisolone; Prednisone; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine | 1992 |
Relations between the penetration, binding and average concentration of cytostatic drugs in human tumour spheroids.
Topics: Antineoplastic Agents; Autoradiography; Carbon Radioisotopes; Cell Line; Centrifugation; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Humans; Neoplasms; Scintillation Counting; Time Factors; Tritium; Tumor Cells, Cultured | 1992 |
Functional myocardial impairment in children treated with anthracyclines for cancer.
Topics: Adolescent; Blood Pressure; Child; Child, Preschool; Daunorubicin; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Exercise Test; Female; Heart Rate; Humans; Male; Myocardial Contraction; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ventricular Function | 1991 |
[Clinical usefulness of quantitative two-dimensional echocardiographic analysis of segmental kinesis of the left ventricle in monitoring of patients with neoplasms treated with anthracyclines].
Topics: Adolescent; Cardiomyopathy, Dilated; Child; Daunorubicin; Doxorubicin; Echocardiography; Female; Heart; Humans; Male; Myocardial Contraction; Neoplasms | 1991 |
[Systolic time intervals and echocardiography in monitoring adriamycin-treated tumor patients].
Topics: Adult; Aged; Cardiac Output; Cardiomyopathies; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Echocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Systole; Ventricular Function, Left | 1991 |
Delayed cardiac toxicity from anthracycline therapy.
Topics: Arrhythmias, Cardiac; Child; Daunorubicin; Doxorubicin; Follow-Up Studies; Heart; Heart Failure; Humans; Neoplasms | 1991 |
Monoclonal antibody L6-daunomycin conjugates constructed to release free drug at the lower pH of tumor tissue.
Topics: Aged; Animals; Antibodies, Monoclonal; Daunorubicin; Female; Humans; Hydrogen-Ion Concentration; Immunotoxins; Male; Mice; Middle Aged; Neoplasms; Tissue Distribution; Tumor Cells, Cultured | 1991 |
Pharmacokinetics of 4-demethoxydaunorubicin in cancer patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Biological Availability; Daunorubicin; Female; Half-Life; Humans; Idarubicin; Injections, Intravenous; Male; Middle Aged; Neoplasms | 1990 |
Phase I study of weekly intravenous administration of menogaril to adults with solid tumors.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents; Daunorubicin; Dexamethasone; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injections, Intravenous; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin; Prognosis; Thrombocytopenia | 1989 |
Rapid quantitative determination of doxorubicin and its metabolites in biological samples.
Topics: Chromatography, High Pressure Liquid; Daunorubicin; Doxorubicin; Humans; Naphthacenes; Neoplasms; Reference Values | 1989 |
[Serial determination of anthracycline poisoning in children].
Topics: Biopsy; Cardiac Output; Cardiomyopathies; Child; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Endocardium; Heart Failure; Humans; Myocardium; Neoplasms | 1989 |
Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Parenteral; Liver Neoplasms; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1986 |
Phase I and pharmacokinetic study of menogaril administered as a 72-hour continuous i.v. infusion.
Topics: Adult; Aged; Daunorubicin; Drug Evaluation; Female; Half-Life; Humans; Infusions, Intravenous; Kinetics; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1987 |
Pharmacokinetics of 7-con-O-methylnogarol in patients with solid tumors.
Topics: Aged; Daunorubicin; Female; Half-Life; Humans; Infusions, Intravenous; Kinetics; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1987 |
Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Humans; Liver; Liver Function Tests; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1987 |
Phase I clinical and pharmacokinetic trial of oral menogaril administered on three consecutive days.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Biological Availability; Daunorubicin; Drug Evaluation; Female; Half-Life; Humans; Leukopenia; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1988 |
Phase I clinical trial of oral menogaril administered on three consecutive days.
Topics: Administration, Oral; Adult; Aged; Blood Cells; Daunorubicin; Drug Evaluation; Female; Heart; Humans; Liver; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1988 |
[Sensitivity of human tumor heterografts to a spin-labelled rubomycin derivative].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation, Preclinical; Fluorouracil; Humans; Mice; Neoplasms; Neoplasms, Experimental; Spin Labels; Subrenal Capsule Assay; Transplantation, Heterologous | 1988 |
Chemotherapy side effects in pediatric oncology patients: drugs, age, and sex as risk factors.
Topics: Adolescent; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Humans; Male; Nausea; Neoplasms; Prospective Studies; Risk Factors; Sex Factors; Vomiting | 1988 |
Clinically useful doxorubicin analogues.
Topics: Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Humans; Neoplasms | 1987 |
Phase I study of oral idarubicin given with a weekly schedule.
Topics: Administration, Oral; Adult; Aged; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Idarubicin; Leukopenia; Male; Middle Aged; Neoplasms; Risk; Thrombocytopenia | 1986 |
Circumvention of multiple-drug resistance in human cancer cells by thioridazine, trifluoperazine, and chlorpromazine.
Topics: Calmodulin; Cell Line; Chlorpromazine; Daunorubicin; Drug Resistance; Humans; KB Cells; Lysosomes; Neoplasms; Thioridazine; Trifluoperazine; Tritium; Vincristine | 1986 |
Pharmacokinetics of idarubicin (4-demethoxydaunorubicin; IMI-30; NSC 256439) following intravenous and oral administration in patients with advanced cancer.
Topics: Administration, Oral; Adult; Aged; Biological Availability; Daunorubicin; Female; Half-Life; Humans; Idarubicin; Infusions, Intravenous; Kinetics; Male; Middle Aged; Neoplasms | 1987 |
Phase I and clinical pharmacological study of 4-demethoxydaunorubicin (idarubicin) in children with advanced cancer.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Idarubicin; Infant; Leukemia; Metabolic Clearance Rate; Neoplasms | 1987 |
Patterns of anthracycline retention modulation in human tumor cells.
Topics: Bone Marrow; Breast Neoplasms; Daunorubicin; Doxorubicin; Female; Humans; Leukemia; Lung Neoplasms; Microscopy, Fluorescence; Neoplasms | 1987 |
Phase I clinical evaluation of oral and intravenous 4-demethoxydaunorubicin.
Topics: Administration, Oral; Adult; Aged; Agranulocytosis; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Injections, Intravenous; Male; Middle Aged; Neoplasms; Thrombocytopenia | 1985 |
[High-dose treatment].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunorubicin; Doxorubicin; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Humans; Infusions, Parenteral; Leucovorin; Leukemia; Methotrexate; Neoplasms | 1985 |
Perioperative complications in patients with anthracycline chemotherapeutic agents.
Topics: Adolescent; Adult; Anesthesia, General; Animals; Arrhythmias, Cardiac; Child; Child, Preschool; Combined Modality Therapy; Daunorubicin; Doxorubicin; Echocardiography; Humans; Hypotension; Infant; Intraoperative Complications; Monitoring, Physiologic; Neoplasms; Postoperative Complications | 1985 |
Response of therapy-associated acute nonlymphocytic leukemia to intensive induction chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Leukemia; Leukemia, Radiation-Induced; Male; Middle Aged; Neoplasms; Prednisone; Prognosis; Thioguanine; Vincristine | 1985 |
[Antibiotics in the treatment of neoplasms].
Topics: Anti-Bacterial Agents; Cytogenetics; Dactinomycin; Daunorubicin; Humans; Mitomycins; Neoplasms | 1971 |
[Use of various new antibiotics in the therapy of tumors].
Topics: Antibiotics, Antineoplastic; Bleomycin; Daunorubicin; Humans; Neoplasms; Plicamycin | 1972 |
[Selective tumour chemotherapy using oncobiograms (author's transl)].
Topics: Animals; Antineoplastic Agents; Bleomycin; Cricetinae; Culture Techniques; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Drug Evaluation; Drug Resistance; Fluorouracil; Humans; Methods; Methotrexate; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Procarbazine; Radioisotopes; Rats; Scintillation Counting; Thymidine; Triaziquone; Uridine | 1974 |
Letter: Unusual nuclear alterations.
Topics: Animals; Biopsy; Cell Nucleus; Chromatin; Culture Techniques; Daunorubicin; DNA; Doxorubicin; Haplorhini; Heart; Humans; Myocardium; Neoplasms | 1974 |
[The effects of cytostatic agents on short-term cultures (3H-uridine incorporation) and tissue cultures (cell counts) from human tumors (author's transl)].
Topics: Antineoplastic Agents; Bleomycin; Cell Count; Cell Transformation, Neoplastic; Cells, Cultured; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Female; Fluorouracil; Humans; In Vitro Techniques; Methods; Methotrexate; Neoplasms; Ovarian Neoplasms; Podophyllin; Suspensions; Time Factors; Triaziquone; Tritium; Uridine | 1974 |
[Primary selection of the producers of antineoplastic antibiotics specifically interacting with nucleic acids].
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Bacteriophages; Culture Techniques; Dactinomycin; Daunorubicin; DNA; DNA, Bacterial; Flavonoids; Humans; Mannomustine; Methods; Mice; Neoplasms; Neoplasms, Experimental; Nucleic Acids; Rabbits; Rats; RNA; Staphylococcus; Streptomyces | 1966 |
[Efficacy of a new antineoplastic antibiotic, daunomycin, in the therapy of malignant tumors in children].
Topics: Adolescent; Child; Child, Preschool; Daunorubicin; Female; Humans; Infant; Male; Neoplasm Metastasis; Neoplasms; Palliative Care | 1968 |
Studies on the effects of chemicals on the processing of nuclear RNA. Some possible implications with respect to carcinogenesis.
Topics: Adenine Nucleotides; Animals; Antibiotics, Antineoplastic; Benzazepines; Carcinoma, Ehrlich Tumor; Cell Line; Cell Nucleus; Dactinomycin; Daunorubicin; Drug Stability; Neoplasms; Plicamycin; Polynucleotides; Pyrroles; Ribonucleases; RNA | 1971 |
Daunomycin in the treatment of acute leukaemia and neoplastic diseases in childhood.
Topics: Adenocarcinoma; Age Factors; Child; Child, Preschool; Daunorubicin; Female; Hemangiosarcoma; Hodgkin Disease; Humans; Infant; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Neoplasms; Neuroblastoma; Peritoneal Neoplasms; Sarcoma, Ewing; Teratoma; Testicular Neoplasms; Wilms Tumor | 1968 |
1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapy.
Topics: Adult; Aged; Alopecia; Breast Neoplasms; Cyclohexanes; Daunorubicin; Digestive System; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Heart; Humans; Kidney Neoplasms; Leukopenia; Male; Middle Aged; Neoplasms; Nitrosourea Compounds; Ovarian Neoplasms; Parotid Neoplasms; Stomatitis; Thrombocytopenia; Vision Disorders | 1974 |
Adriamycin (NSC-123127) and its analogs.
Topics: Animals; Daunorubicin; DNA; DNA, Neoplasm; Doxorubicin; Humans; Leukemia L1210; Mice; Molecular Conformation; Neoplasms; Structure-Activity Relationship | 1974 |
[Research on optimal dosage schemes in clinical experimentation with antineoplastic agents].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cytarabine; Daunorubicin; Drug Combinations; Glycosides; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Naphthacenes; Neoplasms | 1972 |
[Clinical trial of chemotherapeutic combinations based on the notion of attempted cellular synchronization. Preliminary administration of an antimitotic followed by the use of cycle-dependent or phase dependent product(s)].
Topics: Amino Sugars; Anthraquinones; Antineoplastic Agents; Asparaginase; Cyclophosphamide; Daunorubicin; DNA; Drug Combinations; Drug Tolerance; Female; Hodgkin Disease; Humans; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Mitosis; Neoplasm Metastasis; Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllum; Prednisone; Prognosis; Time Factors | 1972 |
[Chemotherapy of cancer. Hints for continuing medical education].
Topics: Antineoplastic Agents; Busulfan; Chlorambucil; Cyclophosphamide; Cytarabine; Daunorubicin; Education, Medical, Continuing; Fluorouracil; Humans; Melphalan; Mercaptopurine; Methotrexate; Neoplasms; Procarbazine; Triaziquone; Vinblastine; Vincristine | 1974 |
Urinary polyamines in cancer patients.
Topics: Brain Neoplasms; Chemistry, Clinical; Daunorubicin; Female; Hodgkin Disease; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms; Ovarian Neoplasms; Polyamines; Pregnancy; Remission, Spontaneous; Spermidine; Spermine; Teratoma | 1971 |
Observations on toxicity and clinical trials with daunomycin.
Topics: Adult; Animals; Child; Daunorubicin; Dogs; Haplorhini; Humans; Injections, Intravenous; Leukemia; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mice; Neoplasms; Neuroblastoma | 1967 |
[Results obtained with the clinical use of adriamycin].
Topics: Adult; Aged; Amino Sugars; Antibiotics, Antineoplastic; Daunorubicin; Female; Glycosides; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Naphthacenes; Neoplasms; Plasmacytoma; Remission, Spontaneous | 1971 |
Plasma and urinary levels of adriamycin in man.
Topics: Chromatography, Thin Layer; Daunorubicin; Female; Fluorometry; Humans; Injections, Intravenous; Male; Neoplasms | 1972 |
On the reported lack of effectiveness of daunomycin (NSC-82151) and adriamycin (NSC-123127) on solid tumors.
Topics: Animals; Chlortetracycline; Daunorubicin; Doxorubicin; Injections, Intravenous; Lethal Dose 50; Neoplasms | 1972 |
[Antineoplastic drugs: cross resistance in studies on cell cultures].
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Cricetinae; Dactinomycin; Daunorubicin; In Vitro Techniques; Neoplasms; Vincristine | 1971 |
[Daunomycin].
Topics: Animals; Child; Child, Preschool; Daunorubicin; Dogs; Humans; In Vitro Techniques; Infant; Leukemia, Lymphoid; Leukemia, Myeloid; Mitosis; Neoplasms; Nucleic Acids; Rabbits; Rats | 1968 |
[Chimiotherapy of cancers (operational research of its efficiency and its place in therapeutic strategy of neoplasic diseases)].
Topics: Agranulocytosis; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Cyclophosphamide; Daunorubicin; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Methotrexate; Neoplasms; Neoplastic Cells, Circulating; Prednisone; Vinblastine; Vincristine | 1969 |
Bar-shaped nuclear bodies in oral epithelial cells of children receiving chemotherapy for cancer.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Chromatin; Cyclophosphamide; Daunorubicin; Female; Humans; Male; Mercaptopurine; Methotrexate; Mouth Mucosa; Neoplasms; Prednisone; Procarbazine; Vincristine | 1971 |
Clinical exerience with daunomycin (NSC 82151).
Topics: Daunorubicin; Humans; Neoplasms | 1969 |
[Biochemical aspects of neoplasm therapy].
Topics: Asparaginase; Biological Transport; Daunorubicin; DNA; Humans; Neoplasms; RNA | 1971 |
[Daunomycin].
Topics: Daunorubicin; Humans; Neoplasms | 1967 |
[Daunomycin and rubidomycin (new antiblastic drugs)].
Topics: Animals; Daunorubicin; Humans; Leukemia; Neoplasms | 1967 |
The efficacy of a new antineoplastic antibiotic in the treatment of malignant tumours in children.
Topics: Adolescent; Child; Child, Preschool; Daunorubicin; Humans; Neoplasms | 1968 |